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Illustration:
Shape of tryparedoxin peroxidase of Trypanosoma brucei in different
functional states. The oxidized peroxidase of T. brucei forms an almost regular
ring (red) consisting of ten subunits, as inferred from averaged electron
microscopic images. In reaction with a pseudosubstrate, i. e. a tryparedoxin
with Cys43 mutated to Ser, a dead-end intermediate with pentangular
appearance (superimposed yellow net) is formed that mimics the catalytic
intermediate proposed for the reduction of the peroxidase by tryparedoxin.
Original electron micrographs (blue) of reduced tryparedoxin peroxidase are
seen in the background.
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1 Introduction
Today´s Kinetoplastida form a diverse order of flagellated protozoans that
have evolved from an ancient lineage, rooted near the base of the eukaryotic
tree, at least 500 million years ago. They have adopted a lifestyle that has
fascinated generations of biochemists and parasitologists. Kinetoplastida are a
group of protozoa characterized by the presence of a specific organelle, the
kinetoplast (Vickermann, 1976). This structure was observed by early
researchers in light microscopy as basophilic granules near the basal body of
the flagellum. It represents a mitochondrium containing a large mass of
circular mitochondrial DNA.
Diseases caused by some species of the order Kinetoplastida have always
plagued mankind, and today most of them are at least as prevalent as they
have been. The parasites cause diseases in animals, plants, are severely
affecting human health and are retarding agriculture development in less
developed countries. Pathogenic trypanosomatids have digenic life-cycles that
alternate between their mammalian and insect host (see chapter 1.2). At least
about 21 of 30 different Leishmania species have been identified as causative
agents of the cutaneous, mucocutaneous and visceral forms (kala-azar) of
leishmaniasis. These include the L. donovani complex with 3 species (L.
donovani, L. infantum and L. chagasi), the L. mexicana complex with 3 main
species (L. mexicana, L. amazonensis and L. venezuelensis), the subgenus
Viannia and the species L. tropica, L. major and L. aethiopica. The different
species are morphologically indistinguishable, but they can be differentiated by
isoenzyme analysis, molecular methods or monoclonal antibodies.
The most intensively studied members of the genus Trypanosoma are
Trypanosoma brucei brucei, the causative agent of nagana in cattle and the
human pathogen subspecies Trypanosoma brucei gambiense, that causes
west African sleeping sickness and Trypanosoma brucei rhodesiense, the
causative agent of  east African sleeping sickness. The two human pathogen
subspecies are morphologically indistinguishable.
The protozoan parasite Trypanosoma cruzi causes Chagas disease, a
zoonotic disease that can be transmitted to humans and is also called
American trypanosomiasis.
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1.1 Epidemiology of Kinetoplastida
1.1.1 Leishmaniasis
Leishmaniasis is found in parts of about 88 countries, where approximately
350 million people live. Most of the affected countries are in the tropics and
subtropics. The disease is spread in some parts of Mexico, central America,
south America, Asia, the middle east, and Africa. More than 90 % of
cutaneous leishmaniasis cases occur in Iran, Afghanistan, Syria, Saudi Arabia,
Brazil and Peru. More than 90 % of visceral leishmaniasis cases occur in
Bangladesh, Brazil, India and Sudan (see Figure 1.1)(CDC, 2003; WHO,
2003c).
Figure 1.1: Distribution of cutaneous and visceral leishmaniasis. Highly endemic
countries are shown in red. (C.D. Foundation, 2003; WHO, 2003c)
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For cutaneous leishmaniasis 1 – 1.5 million new cases and for visceral
leishmaniasis 500,000 new cases per year are estimated. The overall
prevalence is 12 million people.
1.1.2 Sleeping sickness
There have been three severe epidemics in Africa over the last century: one
between 1896 and 1906, mostly in Uganda and the Congo Basin, one in 1920
in several African countries, and one that began in 1970 and is still in
progress. The disease had practically disappeared between 1960 and 1965.
After that success, screening and effective surveillance were relaxed, and the
disease has reappeared in endemic form in several foci over the last 30 years.
Trypanosoma brucei gambiense (T. b. gambiense) is found in central and west
Africa and causes chronic infection. A person can be infected for months or
even years without developing obvious symptoms. Trypanosoma brucei
rhodesiense (T. b. rhodesiense) is found in southern and east Africa. It causes
acute infection that emerges after a few weeks. It is more virulent than the
other strain and develops more rapidly, which means that it is more quickly
detected clinically. Almost 45,000 cases were reported in 1999, but the World
Health Organization (WHO) estimates that the number of people affected is
higher between 300,000  and 500,000 (WHO, 2003c).
Countries are divided in four categories in terms of prevalence. In each
country the spatial distribution of the disease is very diverse; it is found in foci
and micro-foci. (i) Countries where there is an epidemic of the disease, in
terms of very high cumulated prevalence and high transmission: Angola,
Democratic Republic of Congo and Sudan; (ii) highly endemic countries,
where prevalence is moderate but increase is certain: Cameroon, Central
African Republic, Chad, Congo, Côte d´Ivoire, Guinea, Mozambique, Uganda
and United Republic of Tanzania; (iii) countries where the endemic level is low;
(iv) countries whose present status is not clear (see Figure 1.2) (WHO,
2003a).
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Figure 1.2: Depending on their level of disease prevalence, endemic countries can be
classified in four major levels of endemicity (WHO, 2003a): epidemic countries (red);
high endemic countries (deep purple); endemic countries (purple); countries at risk
(light purple).
1.1.3 Chagas disease
Detected in Andean mummies dating back to 4000 BC (Guhl et al., 1999),
Chagas disease started to expand at the end of the 19th century and reached a
peak in the first half of the 20th century. Chagas disease occurs throughout
Mexico and central and southern America, and continues to pose a serious
threat to health in many countries of that region (see Figure 1.3).
Figure 1.3: Geographical distribution of Chagas disease (WHO, 2002).
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Furthermore, due to recent significant population migration from endemic
countries towards developed countries, the threat of the disease is expanding
to reach areas outside the traditional geographic boundaries (WHO, 2002).
Chronic Chagas disease affects a significant number of individuals in Latin
America, mostly the poorest of the poor. The overall prevalence of human
Trypanosoma cruzi infection is estimated at 16 – 18 million cases.
Approximately 120 million people, i. e. 25 % of the inhabitants of Latin
America, are at risk of infection.
1.2 Infection and disease
1.2.1 Leishmaniasis
Leishmaniasis is a vector-born disease that is transmitted by the bite of an
infected female phlebotomine sandfly and caused by obligate intracellular
protozoa of the genus Leishmania. Sandflies are primarily infected by biting an
infected animal (i. e. rodents or dogs) or humans. A parasitized female sandfly
takes a blood meal from a human host and injects the amastigote form of the
parasite to the blood of the human host. In the amastigotic stage the parasites
are infective and can affect different tissues depending in part on the
Leishmania species (see Figure 1.4).
Figure 1.4: Leishmaniasis is transmitted by the bite of a female phlebotomine sandfly.
The sandflies inject the infective stage, promastigotes, during a blood meal.
Promastigotes are phagocytized by macrophages (1) and transform into amastigotes
(2). Amastigotes multiply (3) and are released to the circulation, where they can  infect
different tissues (back to 1) or infect sandflies during a blood meal of an infected host
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(4). In the gut of the fly they transform to promastigotes (5), attach to the epithel of the
gut (6) transform to the infective stage and migrate to the proboscis later on (7)
(Lucius and Loos-Frank, 1997).
The leishmaniasis can be classified into four main forms. The factors
determining the form of disease include leishmanial species, geographic
location and immune response of the host.
1. Visceral leishmaniasis (kala-azar) is characterized by irregular bouts of
fever, substantial weight loss, swelling of the spleen and liver and anaemia.
Visceral leishmaniasis is the most severe form of the disease which, if
untreated, has a mortality rate of almost 100 %.
2. Cutaneous leishmaniasis is the most common form and characterized by
one to 200 sores on the skin. The sores can change in size and
appearance over time, which self-heal within a few months but leave
unsightly scars.
3. Mucocutaneous leishmaniasis begins with skin ulcers which spread,
causing dreadful and massive tissue destruction, especially of the nose and
the mouth.
4. Diffuse cutaneous leishmaniasis produces disseminated and chronic skin
lesions resembling those of lepromatous leprosy and is difficult to treat
(WHO, 2003d).
For treatment, first-line drugs are pentavalent antimonials. Recently,
resistance to drugs has been reported, requiring the use of more toxic drugs
as the second-line drugs, amphotericin B and Ambisome. Most available drugs
are costly, require long treatment regimes and are becoming more and more
ineffective. Another strategy is to control the vector, but vector and reservoir
host control measures are expensive, requiring good infrastructures and
maintenance. Infection can be prevented by avoidance of sandfly bites through
use of repellents or insecticides (WHO, 2003d).
1.2.2 African trypanosomiasis
Domestic and wild animals are the reservoir of T. b. rhodesiense. They can
also be infected by T. b. gambiense, though the precise role of this reservoir is
not well known. Infection starts with a blood meal on a mammalian host. An
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infected tsetse fly (genus Glossina) injects metacyclic trypomastigotes into
skin tissue. The life-cycle can start (see Figure 1.5).
Figure 1.5: The tsetse fly injects the metacyclic trypomastigotes during a blood meal
(1). They transform into bloodstream trypomastigotes (2) and replicate by binary
fission. The tsetse fly can get infected by taking a blood meal from an infected host
(3). The procyclic trypomastigotes (4) transform into mesocyclic trypomastigotes (5) in
the gut of the fly. Later, when they reach the saliva they transform to epimastigotes,
attached to the saliva (6). At the end they transform to infective trypomastigotes (7).
The cycle in the fly takes approximately 3 - 5 weeks (Lucius and Loos-Frank, 1997).
The disease occurs in two forms: a chronic one caused by T. b. gambiense,
which occurs in west and central Africa; and an acute form, caused by T. b.
rhodesiense, which occurs in eastern and south Africa. The chronic infection
lasts for years, while the acute form may last for only weeks before death
occurs, if treatment is not administered. The early phase entails bouts of fever,
headaches, pain in the joints and itching. The second, known as the
neurological phase, begins when the parasite crosses the blood-brain barrier
and infects the central nervous system. This is when the characteristic signs
and symptoms of the disease appear: confusion, sensory disturbances and
poor coordination. Disturbance of the sleep cycle, which gives the disease its
name, is the most important feature. If the patient does not receive treatment
before the onset of the second phase, neurological damage is irreversible
even after treatment (WHO, 2003d).
If the disease is diagnosed early, the chances of cure are high. Suramine and
Pentamidine are used as first phase drugs and Melarsoprol and Eflornithine
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are used as treatment in the second phase of infection. In short, most drugs
are old, difficult to administer in poor conditions, toxic, and by no means
always successful (WHO, 2003d).
1.2.3 Chagas disease
There are various strains of Trypanosoma cruzi (T. cruzi), which differ in terms
of epidemiology, pathogenicity, response to treatment, biochemistry or
immunogenicity. The tendency is to assign all isolated strains into two major
groups, defined as I and II. T. cruzi I is extremely widespread within the
sylvatic cycle, highly associated with opossums and may represent the original
form of T. cruzi. T. cruzi II seems primitively associated with rodents and with
Triatoma infestans. Of more than 100 recognized triatome species, only about
ten are widespread colonizers of human dwellings and are highly
anthropophilic (Prata, 2001).
Parasites can be transmitted to humans in three ways:
1. By blood-sucking triatomes, which live in cracks and crevices of poor-quality
houses, usually in rural areas. They emerge at night to bite and suck blood.
The faeces of the insect, left after a blood meal, contain parasites, which
can enter the wound usually when it is scratched or rubbed (see Figure 1.6).
2. Through blood transfusion with infected blood. The risk of acquiring the
infection after transfusion is about 20%.
3. The third and most important route is the congenital one. The likelihood of
congenital transmission in children of chagasic mothers ranges from 1 – 10
%. This type of transmission may also occur outside endemic areas.
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Figure 1.6: Inside the host the trypomastigotes invade cells (1), where they
differentiate into amastigotes (2). They multiply and transform to trypomastigotes (3)
and are then released into the circulation as bloodstream trypomastigotes (4). They
infect a variety of tissues and transform back to amastigotes (back to 2). The bugs
become infected by sucking human or animal blood that contains circulating parasites
(5). The ingested trypomastigotes transform into epimastigotes in the vector´s midgut
(6) and differentiate into infective metacyclic trypomastigotes in the hindgut (7)
(Lucius and Loos-Frank, 1997).
Usually a small sore develops at the bite where the parasite enters the body. If
this is near the eye, the eyelid, becomes swollen (known as Romaña´s sign).
Within a few days, fever and swollen lymph nodes may develop. This initial
acute phase may cause illness and death, especially in young children. More
commonly, patients enter a symptomless phase lasting several months or
years. During that time the parasites are invading most organs of the body,
often causing heart, intestinal and oesophageal damage and progressive
weakness. In 32 % of those infected people, fatal damage to the heart and
digestive tract occurs (WHO, 2003b).
Two drugs, nifurtimox and benznidazol, are capable of curing at least 50 % of
recent infections. These products are active in the acute and short-term
chronic phase. However, they have little or no activity in long-term chronic
forms of the disease. As well, both drugs have serious and frequent side-
effects so their use has been limited.
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1.3 Phagocytes and oxidative stress
As described in chapter 1.2 the promastigotes of the order Kinetoplastida are
phagocytized by macrophages and transform into non-motile, oval
amastigotes with retracted flagella. They are obligate intracellular pathogens
that are major  causes of human diseases and deaths worldwide. Such
intracellular pathogens need specialized survival strategy to survive in the
mammalian host.
Phagocytes are the first line of defense against invading pathogens, killing and
disposing them with impressive efficiency. They produce a battery of reactive
oxidizing agents, which also cause harm on the nearby tissues. These
oxidants are generated by four enzymes: NADPH oxidase, superoxide
dismutase, nitric oxide synthase and myeloperoxidase (Babior, 2000).
NADPH oxidase is a membrane-bound enzyme that catalyzes the production
of superoxide (O2−) from oxygen and NADPH:
It is dormant in the resting phagocyte but comes to life, when the cell is
activated (i. e. by phagocytized bacteria or inflammatory polypeptides).
Superoxide dismutase catalyzes the conversion of O2− to H2O2 and oxygen.
It is called a dismutation, because the substrate (O2−) reacts with itself to give
an oxidized product (i. e. oxygen) and a reduced product (i. e. H2O2).
Nitric oxide synthase catalyzes the production of nitric oxide (NO) from
arginine, oxygen and NADPH (Beckman and Koppenol, 1996).
There are two general varieties of NO synthase: constitutive and inducible.
The constitutive form is a low-activity enzyme that produces small amounts of
NO as signaling molecules (Murad, 1994). It is found in vascular endothelium
and in the central nervous system. The inducible form is a high-activity
enzyme that is produced by phagocytes, when they are suitably stimulated
(Weinberg et al., 1995).
2 O2 + NADPH → 2 O2− + NADP+ + H+
2 O2− + 2 H+ →  O2 + H2O2
Arginine + oxygen + NADPH → NO + citrulline + NADP+
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Myeloperoxidase catalyzes the oxidation of halide ions (Cl−, Br−, I−) to
hypohalous acids at the expense of hydrogen peroxide.
The H2O2 employed in this reaction is produced by the dismutation of O2−. The
enzyme can oxidize any of the three halide ions listed above and in addition
can oxidize thiocyanate (SCN−) (Babior, 2000).
H2O2 is able to generate the most aggressive •OH in the presence of transition
metals. Simultaneously, hydroperoxides of unsaturated fatty acids will be
directly formed by activated lipoxygenases and cyclooxygenases or may be
generated indirectly by •O2−/H2O2-driven unspecific lipid peroxidation
(Brigelius-Flohé et al., 2002).
Those responses to everything recognized as foreign are meant to eliminate
intruded pathogens, but have also harmful side-effects to the host´s tissue.
Both, the affected host and the pathogen had to develop strategies for the
elimination of reactive oxygen intermediates (ROI) and reactive nitrogen
intermediates (RNI). These strategies vary for phylogenetically diverse
species, which offers the opportunity of selective inhibition of the pathogen´s
defense mechanism, without affecting the host´s self-protection (Budde and
Flohé, 2002).
1.4 Self-protection of the mammalian host
The best known H2O2 eliminating enzyme is catalase, which dismutates H2O2
to H2O and molecular oxygen (Schonbaum and Chance, 1976; Wood et al.,
2003b).  But in all mammalian cells catalase appears to be largely restricted to
the peroxisomes, where it is involved in detoxifying the H2O2 derived from the
peroxisomal metabolism. Equally efficient as catalase are the selenium-
containing glutathione peroxidases (GPx) (Flohé et al., 1972; Günzler et al.,
1972). Beneath H2O2  they detoxify a wide range of organic hydroperoxides
(Flohé and Brigelius-Flohé, 2001). Five variants of glutathione peroxidases
(GPx-1 - GPx-5) are known in mammals to date. GPx-5 is the only known non-
selenium containing peroxidase. They have all in common, that they detoxify
hydroperoxides at the expense of NADPH via glutathione (GSH) and
glutathione reductase, with the exception of GPx-3, which additionally uses
glutaredoxin and thioredoxin (Trx). Another H2O2 reducing enzyme family are
the peroxiredoxins (Prx). Many organisms produce more than one isoform,
Cl− + H2O2 → OCl− + H2O
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including at least six Prxs identified in mammalian cells (PrxI - PrxVI)
(Hofmann et al., 2002; Wood et al., 2003b). They share a common reactive
Cys residue in the N-teminal region, are capable of serving as a peroxidase,
and involve thiols like thioredoxin or glutathione as the electron donors. These
Prx family members are located in the cytosol, mitochondria, peroxisomes or
plasma, that are all sites of ROI production (Fujii and Ikeda, 2002) (see Figure
1.7).
Peroxidases
Products
LMW Mediator
Flavoproteins
Reductant
Substrates
Se
PrxI-IV Prx VI
NADPH
GSH
ROH,
H2O
ROH,
H2O
H2O2,ROOH ?
TrxR
Trx Grx
Se Se Se Se
CXXC - 
proteins
GR
GPx-3 GPx-1 GPx-2 GPx-4 GPx-5
Figure 1.7: Thiol-mediated hydroperoxide metabolism in mammals. Homologous
proteins are shown in identically marked circles. Se indicates redox-active selenium.
TrxR, thioredoxin-reductase; GR, glutathione reductase; Trx, thioredoxin; Grx,
glutaredoxin; Prx, peroxiredoxin; GPx, glutathione peroxidase (Budde and Flohé,
2002).
1.5 Detoxification of hydroperoxides in trypanosomatids
As the production of reactive oxygen intermediates (ROI) is an important
microbicidal strategy used by the mammalian host against invading
pathogens, the localization of the parasites within the host and the biochemical
mechanisms used to detoxify ROI is a fundamental aspect of the host-parasite
interaction. There are pronounced differences between the antioxidant
machinery of trypanosomatids and other eukaryotes. Trypanosomatids lack
catalase and selenium-containing glutathione peroxidases (Flohé et al., 1999).
As much as 70 % of their glutathione is converted to the N1,N8-bis-
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(glutathionyl)-spermidine adduct, trypanothione (Fairlamb and Cerami, 1992).
Trypanothione [T(SH)2] is maintained in the reduced state by a trypanothione
reductase (TR), a member of the disulfide reductase family, with high
sequence homology to glutathione reductase (Fairlamb and Cerami, 1992).
The downstream part of the trypanosomatid peroxide metabolism is quite
distinct from the analogous mammalian system. The component accepting the
reduction equivalents from trypanothione is tryparedoxin (TXN), which is
related to the thioredoxin family. Tryparedoxin itself is a substrate for the
tryparedoxin peroxidase (TXNPx), which reduces H2O2 and organic
hydroperoxides (Gommel et al., 1997; Nogoceke et al., 1997) (see Figure 1.9)
Trypanothione reductase is common to Chrithidia, Trypanosoma and
Leishmania species (Fairlamb and Cerami, 1992), but has also been detected
in nonparasitic Euglena gracilis (Montrichard et al., 1999). The enzyme was
crystalized from two species, T. cruzi (Krauth-Siegel et al., 1987) and C.
fasciculata (Hunter et al., 1990; Kuriyan et al., 1991) and studied extensively
by radiographic analysis, steady-state kinetics and rational mutagenesis
(Fairlamb and Cerami, 1992). Moreover, the results of disruption of the TR
gene in T. brucei  has confirmed their absolute necessity for the survival of the
parasites in macrophages (Krieger et al., 2000). Blocking the TR activity by a
dominant-negative approach in L. donovani resulted in a down-regulation of
the TR activity up to 85 % (Tovar et al., 1998). A conditioned knock-out of
trypanothione reductase in T. brucei brucei resulted in increased sensitivity to
H2O2 exposure, loss of virulence and arrest of proliferation (Krieger et al.,
2000).  That data complies with previous failures to obtain any viable clones in
which the trypanothione reductase gene was knocked out constitutively
(Dumas et al., 1997).
Trypanothione is the essential redox mediator in trypanosomatids comprising
the genera Crithidia, Leishmania and Trypanosoma (Fairlamb and Cerami,
1985). It is provided by de novo synthesis from spermidine, glutathione and
ATP (Henderson et al., 1990; Koenig et al., 1997; Oza et al., 2002; Comini et
al., 2003) and regenerated from its oxidized cyclic disulfide form by
trypanothione reductase (see Figure 1.8).
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Figure 1.8: Synthesis of trypanothione: The first step (1) of the reaction is catalyzed by
glutathionyl-spermidine synthetase (GspS) and the second step (2) of the reaction is
catalyzed by an enzyme called trypanothione synthetase (TryS).
The two distinct enzymes had been isolated from C. fasciculata having GspS
or TryS activity (Smith et al., 1992; Koenig et al., 1997). So it was a big
surprise to find a single gene in T. cruzi, T. brucei brucei and C. fasciculata,
which encodes for a protein with both, GspS and TryS activity (Oza et al.,
2002; Comini et al., 2003; Comini et al., 2003, unpublished)
Tryparedoxins (TXNs) are redox-active proteins which were discovered first in
C. fasciculata (Nogoceke et al., 1997; Montemartini et al., 1998a; Guerrero et
al., 1999), later identified in T. cruzi (Lopez et al., 1997), T. brucei (Lüdemann
et al., 1998), and Leishmania infantum (Castro H. et al., 2003, unpublished).
They differ from typical thioredoxins by their active site motif WCPPCR. CXXC
motifs in general are characteristics of proteins reversible catalyzing the
reduction of disulfides and are common in the thioredoxin superfamily. Due to
several insertions up to 5 kDa, TXNs are considerable larger than
thioredoxins. Functionally, TXN transfers reduction equivalents from
trypanothione to tryparedoxin peroxidase, which is a peroxiredoxin. Apart from
being a reducing substrate for TXNPx, TXN was shown to support also
ribonucleotide reductase of T. brucei, thus being relevant for DNA synthesis
(Dormeyer et al., 2001; Krauth-Siegel and Schmidt, 2002) (see Figure 1.9).
Peroxiredoxins have received considerable attention in recent years as a new
expanding family of thiol-specific antioxidant proteins (Chae et al., 1994a;
Chae et al., 1994b). They exert their protective antioxidant role in cells through
their peroxidase activity, whereby hydrogen peroxide, peroxynitrite and a wide
range of organic hydroperoxides are reduced and detoxified (Poole and Ellis,
1996; Bryk et al., 2000; Hofmann et al., 2002). Indeed, these enzymes are
truly ubiquitous, having been identified in yeast, plant and animal cells,
including both protozoan an helminth parasites, and most, if not all, eubacteria
and archaea. Peroxiredoxins use redox-active cysteines to reduce peroxides
and were originally divided into two categories, the 1-Cys and the 2-Cys
peroxiredoxins, based on the number of cysteinyl residues directly involved in
catalysis. The TXNPxs belong to the 2-Cys Prx in analogy to peroxiredoxins of
GSH + Spermidine  ATP/Mg2+; GspS   N1(or N8) -glutathionyl-spermidine (Gsp) (1)
Gsp + GSH  ATP/Mg2+; TryS   T(SH)2 (2)
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other species, the alkyl hydroperoxide reductase (AhpC) of bacteria (Wood et
al., 2002), thioredoxin peroxidase of yeast (Chae et al., 1994a) and some
mammalian peroxiredoxins (Chae et al., 1999). The reaction center of
tryparedoxin peroxidase of Kinetoplastida is presumed to be build-up by two
identical, invertedly orientated subunits. The oxidized proximal cysteine (C52)
first reacts with the distal one (C173´) of the co-reacting second inverted
subunit of the oligomeric enzyme (Budde et al., 2003a), before specific
reduction can start.
GSH
ATP
ADP
GSH-spermidine
synthase (GspS)
GSH-spermidine
Trypanothione
synthase (TryS)
ATP
ADP
Ribonucleotide reductase
R1(S)2
R1(SH)2
dNTP´s
Ribonucleotide 
reductase
NADPH
NADP
TRred
TRox
T(SH)2 ROH + H2O
ROOH
TXNPxred
TXNPxox
TXNred
TXNoxTS2
Figure 1.9: The unique hydroperoxide detoxification cascade in Kinetoplastida. The
terminal peroxidase [tryparedoxin peroxidase (TXNPx)] reduces hydroperoxide at the
expense of NADPH. Tryparedoxin (TXN) reduces tryparedoxin peroxidase (TXNPx) and
is itself reduced by trypanothione [T(SH)2]. Oxidized trypanothione is recycled by
trypanothione reductase (TR). Trypanothione is synthesized  by glutathione-
spermidine synthase (GspS) and trypanothione synthase (TryS) at the expence of two
molecules of ATP. In some cases both reactions are triggered by one enzyme. The
synthesis of deoxyribonucleotides (dNTPs) by ribonucleotide reductase is linked to
the peroxide detoxification mechanism in T. brucei  as this reaction is catalyzed by
tryparedoxin.
It was shown by immunohistochemistry, that the localization of TXN and
TXNPx of C. fasciculata is restricted to the cytosol. But recently,
peroxiredoxins with mitochondrial targeting sequences have been reported in
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T. cruzi (Wilkinson et al., 2000b), L. infantum (Wilkinson et al., 2000a; Castro
et al., 2002a), and T. brucei (Tetaud et al., 2001).
1.6 Objectives of the study
In Kinetoplastida, tryparedoxin peroxidases are the terminal peroxidases of a
unique cascade of oxidoreductases that reduce hydroperoxides at the
expense of NADPH. Enzymatic characterizations were reported for the
cytosolic form of TXNPxs of Crithidia fasciculata (Nogoceke et al., 1997),
Leishmania major (Levick et al., 1998), Trypanosoma cruzi (Guerrero et al.,
2000a), Leishmania donovani (Flohé et al., 2002a), and Leishmania infantum
(Castro unpublished), but no one for the Trypanosoma brucei species.
The objectives of this study was to characterize the hydroperoxide
detoxification system of T. brucei brucei. The main part of this work will focus
on the TXNPx of Trypanosoma brucei brucei, which is nearly identical to the
TXNPx of T. b. rhodesiense.
1. Like other TXNPxs, the TbTXNPx (tryparedoxin peroxidase of
Trypanosoma brucei brucei) has to be tested for different peroxides
including organic and lipid hydroperoxides.
2. The tryparedoxin peroxidase nature of the TbTXNPx has to be clarified by
using thioredoxin of E. coli or glutathione as reductants.
3. A kinetic pattern for TbTXNPx, LiTXNPx and LiTXN will be evaluated in this
thesis and compared to the previous investigations of related enzymes.
4. Specifically we will investigate the question, how oxidation and reduction or
substrate binding affect the molecular size and shape of TbTXNPx and the
mitochondrial TXNPx of Leishmania infantum (LimTXNPx).
5. We wanted to clarify the question, if all ten binding sites of the decameric
TbTXNPx are accessible for its substrates or not.
6. The reaction mechanism of the reductive part of the TXNPx, should be
compared with the hypothetical thesis.
7. Models of TXN interacting with trypanothione will be supported by
mutagenesis studies and measurements of TXN with an inhibitory
pseudosubstrate.
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2 Methods and materials
2.1 Chemicals
Most chemicals used in this study were of the highest purity grade available
and were obtained from:
• J. T. Baker B. V., Denventer, Netherlands
• Merck, Darmstadt, Germany
• Serva Feinbiochemica GmbH & Co., Heidelberg, Germany
• Sigma-Aldrich, Taufenkirchen, Germany
2.2 Parasite strain and culture procedure
The procyclic Trypanosoma brucei brucei strain PC 117 (VSG variant 117 from
the cell line MITat 1.4) was kindly provided by Dr. Friedemann Hesse (GBF,
Braunschweig, Germany).
The promastigotes were cultivated under logarithmic growth conditions (2 x
104  to 1 x 107 parasites per ml) at 27 °C in supplemented 1 x MEM-medium
(Duszenko et al., 1992) (see Table 2.1).  Cell growth was monitored by
counting the parasites in a Neubauer chamber.
18                                                                                                          METHODS AND MATERIALS
Table 2.1: Composition of completed 1 x MEM-medium for cultivation of procyclic
trypanosomes:
minimum essential medium (MEM), pH 7.4
10 x MEM (Invitrogen, Karlsruhe, Germany) 100 ml/l
100 x non-essential amino acid solution
(Sigma-Aldrich, Taufenkirchen, Germany)
10 ml/l
HEPES for cell culture (Roth, Karlsruhe,
Germany)
7140 mg/l (30 mM)
L-Phenylalanine (Sigma-Aldrich,
Taufenkirchen, Germany)
68 mg/l (0.6 mM)
L-Ornithine/HCl (Sigma-Aldrich, Taufenkirchen,
Germany)
10 mg/l (59 µM)
Adenosine (Sigma-Aldrich, Taufenkirchen,
Germany)
12 mg/l (45 µM)
L-Glutamine (Invitrogen, Karlsruhe, Germany) 10 ml/l (2 mM)
Sodium-pyruvat (Sigma-Aldrich,
Taufenkirchen, Germany)
220 mg/l (2 mM)
L-Proline (Serva, Heidelberg, Germany) 600 mg/l (5.2 mM)
Hemin (ICN, Costa Mesa, CA, USA) 25 mg/l (0.25 mM)
solved in 0.1 N NaOH
Fetal calve serum (heat inactivated for 30 min.
at 60 °C, Biochrom KG, Berlin, Germany)
10 % (v/v)
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2.3 Bacterial strains and culture procedure
2.3.1 Bacterial strains
E. coli strains used in this study are listed in Table 2.2:
Table 2.2: E. coli strains and their characteristics:
E. coli strain genotype and relevant phenotype reference
E. coli Tuner (DE3) F- ompT hsdSB (rB- mB-) gal dcm
lacY1 (DE3)
Novagen (Madison,
WI, USA)
E. coli BL21 (DE3) F- ompT hsdSB (rB- mB-) gal dcm (DE3) Novagen (Madison,
WI, USA)
E. coli Nova Blue endA1 hsdR17(rK12- mK12+) supE44
thi-1 recA1
gyrA96 relA1 lac[F´proA+B+
lacIqZ∆M15::Tn10(TcR)]
Novagen (Madison,
WI, USA)
E. coli DH5α supE44 ∆lacU169(Φ80 lacZ ∆M15)
hsdR17 recA1 endA1 gyrA96 thi-1
relA1
(Hanahan, 1983)
E. coli  SURE e14- (McrA-) ∆(mcrCB-hsdSMR-
mrr)171 endA1 supE44 thi-1 gyrA96
relA1 lac recB recJ sbcC umuC::Tn5
(Kanr) uvrC [F´proAB lacIqZ∆(M15
Tn10 (Tetr)]
Stratagene
(Amsterdam,
Netherlands)
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2.3.2 Plasmids
Plasmids used in this study are summarized in Table 2.3.
Table 2.3: Plasmids and their properties:
plasmids properties reference
pET-22b(+) IPTG-inducible
expression vector (5.5
kb), T7 promoter, T7
terminator, C-terminal
His-tag, lac operator,
pBR322 ori, ampicillin
resistent
Novagen (Madison, WI,
USA)
pET-24a(+) IPTG-inducible
expression vector (5.3
kb), T7 promoter, T7
terminator, C-terminal
His-tag, lac operator,
pBR322 ori, kanamycin
resistent
Novagen (Madison, WI,
USA)
pET-28c(+) IPTG-inducible
expression vector (5.4
kb), T7 promoter, T7
terminator, N-terminal
His-tag with thrombin
restriction site, lac
operator, pBR322 ori,
kanamycin resistent
Novagen (Madison, WI,
USA)
2.3.3 Cultivation of E. coli
E. coli strains DH5α, Nova blue and SURE were used for plasmid
transformation and replication. The strains BL21(DE3) and Tuner(DE3) were
used for expression of recombinant proteins under the control of the T7 RNA-
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polymerase promoter. The cells were cultured at 25 – 37 °C in LB medium on
a rotary shaker operated at 160 rpm (Certomat U, B. Braun, Melsungen,
Germany), in Erlenmeyer flasks filled up with not more than 20 % of their total
volume. For strains carrying plasmids, selection was performed by addition of
200 µg/ml ampicillin or 100 µg/ml kanamycin to the medium. For short term
storage strains were conserved on agar plates at 4 °C for one month; for long
term storage a liquid culture containing 50 % glycerol was stored at –80 °C.
Table 2.4: Composition of the Luria-Bertani (LB) medium. The pH was adjusted to pH
7.4 with 5 N NaOH. For the preparation of agar plates 1.5 % Agar (Difco, Detroit, MI,
USA) was supplemented to the liquid LB-medium.
Bacto-Tryptone (Difco, Detroit, MI, USA) 10 g
Bacto-Yeast extract (Difco, Detroit, MI, USA) 5 g
NaCl p.a. 10 g
dest. H2O ad 1 l
2.4 Methods used in molecular biology
Most of the molecular biology methods used in this study were according to
Sambrook et al. (2001).
2.4.1 Isolation of genomic DNA from T. brucei brucei
Genomic DNA was prepared from the late logarithmic phase of the
promastigote culture (5 x 107 parasites). The cells were disrupted in a Mikro-
dismembranator S (Braun, Melsungen, Germany), containing 100 µl glass
beads (425 – 500 µm diameter, Sigma-Aldrich, Taufenkirchen, Germany). The
cell suspension was applied to a QIA-shredder (Qiagen, Hilden, Germany) to
remove the glass beads and the DNA was afterwards purified with the DNeasy
tissue kit (Qiagen, Hilden, Germany).
2.4.2 Purification of DNA
1/10 volume of 3 M sodium acetate (pH 4.8) and 2 volume of 95 % ethanol (p.
a.) were added to the DNA solution, mixed briefly and incubated on ice for 10
min. The sample was centrifuged for 30 min at 20,000 x g. The DNA pellet was
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washed two times with 70 % ethanol (centrifuged for 15 min at 4 °C and
20,000 x g), air-dried and dissolved in an appropriate volume of deionized
water or TE buffer (pH 8.0)(see Table 2.5) and stored at –20 °C.
Table 2.5: Composition of TE-buffer:
10 mM Tris-HCl
1 mM EDTA
2.4.3 Quantification of nucleic acids
2.4.3.1 Measurement of absorbance
The concentration-dependent absorbance of nucleotids at 260 nm can be
used to estimate the concentration of DNA solutions. The nucleic acid solution
was diluted 1:50 or 1:100 with water. 100 µl (water as reference) was added
into a quarz cuvette, absorbance was measured at 260 nm and 280 nm. An
OD260 of 1 roughly equals 50 µg/ml double stranded DNA. A carefully prepared
nucleic acid solution has a ratio of OD260/OD280 between 1.5 to 2.0.
2.4.3.2 Quantification in agarose gels
Alternatively to the method described above, the concentration of nucleic acids
can be determined by staining the agarose gel with SYBR gold (10,000 x
concentrated in DSMO, Molecular Probes Inc., Leiden, Netherlands). A defined
amount of mass ladder (Gibco BRL, Karlsruhe, Germany) was used as a standard to
run a gel in parallel with the DNA in question. The gel was documented with a digital
camera and analyzed (E.A.S.Y. RH-3 system, Herolab, Wiesloch, Germany).
2.4.4 Oligonucleotides
Oligonucleotides were obtained desalted and lyophilized from Metabion
(Martinsried, Germany), resolved to a concentration of 100 pmol/µl and used
without further purification. Primers used in this study are listed in Table 7.1.
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2.4.5 Polymerase chain reaction (PCR)
The PCR was performed in a total volume of 50 – 100 µl solution with either
Taq DNA Polymerase or ProofStart DNA Polymerase (Qiagen, Hilden,
Germany). The protocol used for DNA amplification is listed in Table 2.6.
Table 2.6: PCR reaction composition:
0.5 –1 µg / 10-500 ng chromosomal template DNA / plasmid
DNA
2.5 units DNA polymerase
200 µMol each dNTP
0.5 - 1 µMol 5´- primer
0.5 –1 µMol 3´- primer
1 x buffer Qiagen PCR buffer containing 15 mM
MgCl2
up to 50 or 100 µl sterile deion. water
The reaction was carried out in a T3 Thermocycler (Biometra, Göttingen,
Germany) as follows: 95 °C  1 min, annealing temperature 1 min 72 °C 3 min
(40 cycles) and 72 °C for 15 min elongation step.
2.4.6 DNA digestion with restriction endonucleases
Restriction enzymes and reagents for cloning procedures were purchased
from MBI Fermentas (St. Leon-Rot, Germany). In each restriction reaction an
amount of 3 units enzyme were used for 1 µg DNA. The amount of buffer
(ionic strength), temperature and duration of the reaction depended on the
specific application.
2.4.7 Agarose gel electrophoresis of DNA
The size of DNA fragments or entire plasmids was determined by analysis on
0.8 – 1 % agarose gels. The necessary amount of agarose was dissolved in 1
x TBE buffer (Table 2.7). DNA was loaded with an appropriate dilution in a 6
fold loading buffer (MBI Fermentas, St. Leon-Rot, Germany) onto the gel using
1 x TBE as running buffer. The electrophoresis was performed at 80 - 100 Volt
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in a Wide Mini-Sub Cell or a DNA Sub Cell gel chamber (BioRad, Munich,
Germany). The agarose gel was stained in a SYBR gold solution (1:10,000 in
TBE) for 30 min and analyzed under UV light.
Table 2.7: Composition of 1 x TBE buffer:
89 mM Tris-base
89 mM boric acid
2 mM EDTA
2.4.8 DNA extraction from agarose gels
For DNA extraction from an agarose gel, the QIAquick Gel Extraction Kit from
Qiagen (Hilden, Germany) was used. Elution of the DNA was accomplished
either with elution buffer (10 mM Tris-HCl, pH 8.5) or sterile deionized H2O.
2.4.9 DNA sequencing
Nucleotide sequencing of DNA was carried out using an ABI PRISM Dye
Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Shelton, CT,
USA). Samples containing fluorescence-labeled dideoxynucleotid terminators
were processed on a 373A Applied Biosystems DNA Sequencing System
(Applied Biosystems, Darmstadt, Germany). Homology analysis between
sequences was performed using the Vector NTI Suite 6.0 (InforMax. Inc.,
Oxford, UK) multiple sequence alignment program.
2.4.10 Ligation
For the ligation of cohesive termini, the molar ratio of insert/plasmid was
approximately 3:1 in T4 DNA ligase buffer, using 1 Weiss unit T4 ligase
(Roche, Mannheim, Germany) per 1 µg DNA in 20 µl. The reaction was carried
out at 16 °C over night. For electroporation into E. coli the traces of salts were
removed by dialysis. A volume of 20 µl ligation reaction was dropped on a filter
membrane (0.025 – 0.05 µM, Millipore, Schwalbach, Germany) floating on
deionized H2O and dialyzed for 20 minutes.
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2.4.11 Transformation of DNA into E. coli
2.4.11.1 Electroporation
A single clone of E. coli was transferred from an LB-agar plate to 20 ml LB
medium and shaken at 37 °C over night. A volume of 500 ml was inoculated
with 5 ml of this over-night culture and cultured at 37 °C for 2 – 5 hours until an
OD600 of 0.6 to 0.9 was reached. The cells were cooled on ice for 30 min and
harvested at 4 °C, 5,000 x g for 15 min (centrifuge: RC5C, Kendro, Hanau,
Germany) and washed once with 500 ml, once with 250 ml ice-cold deionized
H2O and with 10 ml cold sterile glycerol (10 %, w/v). The pellet was
resuspended with 2 ml glycerol (10 %, w/v), dispensed in 50 µl aliquots and
immediately frozen in liquid nitrogen. The competent cells were stored at –70
°C.  For the electroporation, 50 µl electrocompetent cells were mixed with 0.1
– 1 µg dialyzed DNA and transferred into a precooled electroporation cuvette
(0.2 cm, BioRad, Munich, Germany). The electroporation was performed at 2.5
kV, 200 Ω and 25 µF (E.coli Pulser, BioRad, Munich, Germany). Cells were
resuspended in 1 ml LB medium, left shaking at 37 °C for 1 hour and then
plated on selective solid medium.
2.4.11.2 TSS Transformation
This method was performed according to Chung et al. (1989). 50 ml LB
medium were inoculated with 1/100 of a freshly prepared over-night culture of
E. coli and grown for about 1.5 hours until the OD600 was 0.5 to 0.7. For each
transformation 1 ml culture was transferred to an Eppendorf cup and
centrifuged for 30 sec at 20,000 x g at room temperature. The cell pellet  was
resuspended in ice cold 100 µl TSS (Table 2.8) and incubated for 30 min on
ice with 0.1 – 1 µg DNA. After adding 0.9 ml LB medium, containing 1 %
glucose the mixture was incubated for an hour at 30 °C and cells were plated
on selective solid medium.
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Table 2.8: Composition of TSS (Transformation and storage solution). The solution
was filter-sterilized and stored in 2 ml aliquots at –20 °C.
50 ml 2 x LB medium pH 6.5
10 g PEG 6000
5 ml DMSO
5 ml MgCl2 or MgSO4
up to 100 ml add deion. water
2.4.12 Site-directed mutagenesis
For site-directed mutagenesis, a first PCR [40 cycles, 47 °C annealing
temperature; Proof Start Taq (Qiagen, Hilden, Germany)] was performed with
the pET22b(+) plasmid containing the wild type gene as template. The
common pET22b(+)-T7 promoter primer and one of the modified reverse
primers and the pET22b(+)-terminator primer and one of the modified forward
primers (see Table 7.1) were used for the first PCR. The PCR products
corresponding to overlapping 5´ and 3´ fragments were purified on a 1 %
agarose gel and eluted (chapter 2.4.7). In the second PCR the products of the
first PCR were used as megaprimers and as templates using both pET22b(+)
T7 primers. The PCR products were digested with the appropriate restriction
endonucleases and ligated into an expression vector. To verify the mutation
and to check for extra mutations the plasmid was sequenced as described in
chapter 2.4.9.
2.4.13 Preparation of plasmid DNA
Single clones were picked for simultaneous inoculation of a master-plate and a
3 ml culture of LB medium (Miniprep) or 50 to 150 ml LB medium (Midiprep),
all incubated over-night at 37 °C.  Both plasmid preparations were performed
according to either the manual of QIAprep Spin Miniprep Kit or HiSpeed
Plasmid Midi Kit (Qiagen, Hilden, Germany).
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2.5 Biochemical methods
2.5.1 SDS polyacrylamide gel-electrophoresis (SDS-PAGE)
SDS polyacrylamid gels were used for determining the molecular weight of
denaturated proteins and to check the efficiency of the protein purifications. In
the majority of cases 15 % acrylamid was used for SDS-PAGE, which was
conducted as described by Laemmli (Laemmli, 1970) and performed with the
minigel-system (11 x 7 x 0.1 cm; Biometra, Göttingen, Germany; see Table
2.9). All samples were diluted 1:2 with double concentrated loading buffer and
denaturated at 95 °C for 10 minutes. Electrophoresis was performed at 60 V,
for collecting the samples in the stacking gel, and was increased to 140 V, for
separating the proteins in the running gel. A broad-range molecular weight
marker (MBI Fermentas, St. Leon-Rot, Germany) was loaded next to the
protein samples for evaluating the molecular weight of the denaturated
proteins.
Table 2.9: Solutions for SDS-PAGE:
2 x SDS loading buffer SDS electrophoresis buffer
100 mM Tris –HCl, pH 6.8 25 mM Tris-base
200 mM DTT 250 mM glycin
4 % (w/v) SDS 0.1 % (w/v) SDS
0.2 % (w/v) bromphenolblue
20 % glycerol
4 x Upper Tris (stacking gel buffer) 4 x Lower Tris (running gel buffer)
0.5 M Tris-HCl pH 6.8 1.5 M Tris-HCl pH 8.8
0.4 % (w/v) SDS 0.4 % (w/v) SDS
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stacking gel (4%) running gel (15%)
0.7 ml Rotiphorese Gel 30 (Roth,
Karlsruhe, Germany)
7.5 ml ml Rotiphorese Gel 30 (Roth,
Karlsruhe, Germany)
1.25 ml stacking gel buffer 3.8 ml running gel buffer
3 ml deionized H2O 3.6 ml deionized H2O
12 µl TEMED 18 µl TEMED
6 µl 40 % (w/v) APS 12 µl 40 % (w/v) APS
2.5.2 Staining methods
2.5.2.1 Hot Coomassie staining
In the majority of cases the Coomassie staining method, with a detection limit
of 0.1 µg protein per band, was used. Polypeptides separated by SDS-PAGE
were fixed for 30 min in a fixing solution (40 % (v/v) ethanol, 10 % (v/v) acetic
acid, 50 % H2O). The staining solution [2 tablets PhastGel Blue R (Amersham
Biosciences, Freiburg, Germany) in 1 l fixing solution] was heated to 55 - 60
°C and the gel was stained for 30 min. After staining the gel was destained in a
destainer-bath, model 556 (BioRad, Munich, Germany), containing 25 % (v/v)
ethanol, 8 % (v/v) acetic acid and 67 % H2O.
2.5.2.2 Silver staining
The silver staining  of SDS-PAGE gels was performed with the Silver Stain
Plus kit from BioRad (Munich, Germany). Silver staining is 30 – 50 fold more
sensitive than the staining by Coomassie blue dye.
2.5.3 Western blotting
This method was used as an analytical method for immunological detection of
proteins on nitrocellulose membranes. The samples to be analyzed were
separated by SDS-PAGE (see chapter 2.5.1). Electrophoretically separated
proteins were blotted to an Immobilon PVDF-membrane (Millipore, Karlsruhe,
Germany) by a Trans-Blot Semi-Dry Transfer Cell (BioRad, Munich,
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Germany). Before blotting, the membrane was wetted in methanol and
equilibrated with the gel in transfer buffer (Table 2.10) for 15 min. The blotting
was performed at 15 V for 30 min at 4 °C. After protein transfer the membrane
was incubated over night at 4 °C in blocking solution [TBS-Tween (Table 2.10)
containing 3 % (w/v) BSA] in order to reduce unspecific antibody binding to the
membrane itself.  The membrane was washed once for 15 min in TBS-Tween
and twice for 5 min in TBS-Tween at room temperature and was then
incubated for 1 hour with a dilution of 1:1000 – 1:5000 of the antiserum in
TBS-Tween. The membrane was again washed as described before and
incubated for one hour with an alkaline-phosphatase conjugated anti-rabbit
IgG (Sigma-Aldrich, Taufenkirchen, Germany) diluted 1:30,000 in TBS-Tween.
The  washing procedure was repeated before incubating the membrane with
the substrate for alkaline phosphatase (Western Blue Stabilized Substrate for
alkaline phosphatase, Promega Co., Mannheim, Germany) until a signal
appeared. Reaction was stopped by rinsing the blot with water.
Table 2.10: Solutions used for Western blot:
Transfer buffer
48 mM Tris-base
39 mM glycin
0.037 % (w/v) SDS
20 % methanol (freshly added)
TBS-Tween (Tris Buffered Saline)
50 mM Tris-base
137 mM NaCl
3 mM KCl
0.05 % (v/v) Tween 20
the pH was adjusted to 7.0
30                                                                                                          METHODS AND MATERIALS
2.5.4 Determination of the protein concentration
2.5.4.1 Method of Bradford
Protein concentration was determined by the method of Bradford (Bradford,
1976) using the BioRad Protein Assay (BioRad, Munich, Germany) and bovine
serum albumin (BSA) as a standard. The protein preparation was diluted with
H2O to the final volume of 800 µl and mixed with 200 µl Bradford reagent. After
15 min of incubation at room temperature the absorbance was determined at λ
= 595 nm using 800 µl H2O with 200 µl Bradford reagent as a blank. The
protein concentration was obtained from the absorbance using a calibration
curve with BSA as standard.
2.5.4.2 Determination of protein concentration by analysis of the amino
acid composition
Amino acid analysis is the most efficient method for determining the quantity of
a protein actually in a sample. The protein was hydrolyzed into its component
and the quantities of the amino acids was determined. By using this data, the
molecular weight, and the sequence of the protein, it is possible to calculate
how much protein was really present in the sample. The analysis of the amino
acid composition was performed by Rita Getzlaff (GBF, Braunschweig,
Germany) with Amino Acid Analysis System Model 420A (Applied Biosystems,
Darmstadt, Germany).
2.5.5 Desalting and buffer-exchange of protein solutions
The buffer of protein solutions was  changed by gelfiltration using a Sephadex
G 25 (Amersham Bioscience, Freiburg, Germany) column. For small amounts
of protein, desalting was performed following the instructions for PD-10
columns (Amersham Bioscience, Freiburg, Germany).
2.5.6 Concentration of protein solutions
For the concentration of protein samples the products Vivaspin 6, Vivaspin 20
and Vivacell 70 (Sartorius, Göttingen, Germany) were used. The appropriate
molecular weight cut off was chosen for each protein and concentrating was
performed following the instructions.
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2.5.7 N-terminal amino acid sequencing
The protein of interest was separated by SDS-PAGE (see chapter 2.5.1),
blotted to an Immobilon PVDF-membrane (Millipore, Schwalbach, Germany)
and stained in a freshly prepared cold Coomassie solution (see chapter
2.5.2.1) until the bands could be seen. The band of interest was cut out,
washed in water and used for sequencing. The N-terminal amino acid protein
sequencing was performed with the protein-sequencer 473A (Applied
Biosystems, Taufenkirchen, Germany)  by Rita Getzlaff (GBF, Braunschweig,
Germany).
2.5.8 MALDI-TOF
The molecular masses of purified proteins were analyzed by matrix-assisted
laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry
at the GBF (Braunschweig, Germany) by a Bruker Reflex-MALDI-TOF or by
Bruker Autoflex (Bremen, Germany).
2.6 Biosynthesis and purification of recombinant proteins
2.6.1 Master seed bank
A master seed bank was created for each expression strain, to have the same
starting conditions for each culture. Bacterial stocks containing each plasmid
with the subcloned gene were prepared from a single colony and stored at –80
°C in LB medium containing 43.5 % (v/v) glycerol.
2.6.2 Induced expression of recombinant proteins
Genes of interest were cloned into the pET expression system of Novagen
(Madison, WI, USA) under the control of an isopropyl-thio-β-D-
galactopyranoside (IPTG) induceable T7 RNA polymerase promoter. E. coli
cells in this study were precultured  shaking at 180 rpm over night at 37 °C in
Luria-Bertani medium containing the appropriate antibioticum and 1 %
glucose. The main culture was inoculated with an OD600 of 0.1 and grown until
an OD600 of 0.6 to 0.9 was reached. At this point the main culture was induced
with 1 mM IPTG and further incubated, shaking at 25 °C until optimal
expression of the protein was performed. E. coli cells were harvested at 5000
x g for 15 min at 4 °C and stored at –20 °C until they were used for further
experiments. Expression experiments were either performed in Erlmeyer
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flasks or, for bigger amounts of protein, in a 5 l Biostat B Fermentor (B. Braun,
Melsungen, Germany).
Table 2.11: List of overexpressed recombinant proteins:
recombinant
protein
plasmid antibiotica
resistence
E. coli strain induction
time
TbTXNH6 pET22b(+) ampicillin Tuner (DE3) 4 hours
TbH6TXN pET28c(+) kanamycin BL21(DE3) overnight
TbTXNC43SH6 pET22b(+) ampicillin BL21(DE3) overnight
TbTXNC40AH6 pET22b(+) ampicillin BL21(DE3) overnight
TbTXNC40SH6 pET22b(+) ampicillin BL21(DE3) overnight
TbH6TXNC43S pET28c(+) kanamycin BL21(DE3) overnight
TbH6TXNPx pET28c(+) kanamycin BL21(DE3) 6 hours
TbTXNPxH6 pET24a(+) kanamycin BL21(DE3) 5 hours
TbTXNPx pET22b(+) ampicillin Tuner(DE3) 6 hours
CfTXN2R129D pET24a(+) kanamycin BL21(DE3) 5 hours
CfTXN2E73R pET24a(+) kanamycin BL21(DE3) 4 hours
LdTXNPxC173S pET24a(+) kanamycin BL21(DE3) 5 hours
2.6.3 Preparation of crude cell extract
All cell extracts were handled on ice in each preparation step. E. coli cells
were resuspended in 10 % of the original culture volume in buffer A, which
was used for the pre-equilibration of the column used for further purification.
The cells were disrupted by sonication (30 sec for volumes up to 1 ml and 3
times 1 min for volumes up to 200 ml) and centrifuged twice at 20,000 x g at 4
°C to remove the cell debris.
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2.6.4 Protein chromatographic methods
For all chromatographic operations the FPLC systems BioLogic Workstation or
BioLogic Duo Flow (BioRad, Munich, Germany) were used. All buffers were
degassed under vacuum and filtrated through a 0.2 µm membrane filter
(Sartorius, Göttingen, Germany).
2.6.4.1 Immobilized-metal affinity chromatography (IMAC)
The purification was mainly performed as described in The QIAexpressionist
(Fifth edition, Qiagen, Hilden, Germany)
For the purification of His-tag fusion proteins, the cells were lysed in buffer A
[50 mM NaH2PO4, 300 mM NaCl, pH 8 (see chapter 2.6.3)].The supernatant
was applied on a Ni2+-nitrilotriacetic acid (Ni-NTA) superflow agarose (Qiagen,
Hilden, Germany) column, washed with 10 volumes of buffer A and eluted with
a gradient from 0 – 100 % of buffer B (buffer A containing 500 mM imidazol).
2.6.4.2 Purification of the native TbTXNPx
2.6.4.2.1 S-Sepharose
S-Sepharose is a strong cation exchanger. The isoelectric point of TbTXNPx is
6.36. Therefore the TbTXNPx were found in the flow through using a buffer at
pH 7.6.
The cells were lysed in 10 mM sodium phosphate buffer pH 7.6 containing 20
mM DTT (freshly added; lysis buffer). The supernatant was applied to a
chromatographic column (5 cm x 7.5 cm) packed with 150 ml  S-Sepharose
fast flow (Amersham Bioscience, Mannheim, Germany) previously equilibrated
in the lysis buffer. The flow through was collected and further purified on
Source Q.
2.6.4.2.2 Source Q
Source Q is a strong anion exchanger containing a quaternary ammonium
anion. The TbTXNPx was bound to the matrix and could be eluted with a salt
gradient.
The flow through of the S-Sepharose was applied to a Source Q column
(Amersham Bioscience, Mannheim, Germany), equilibrated with 10 mM
sodium phosphate buffer pH 7.6 containing 20 mM DTT (buffer A). After
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washing the column with 5 column volumes of buffer A, fractions containing
TbTXNPx were eluted by two bed volumes of 5 % buffer B (= buffer A
containing 1 M NaCl).
2.6.4.2.3 Hydroxyapatite
The fractions eluted from Source Q were loaded to a chromatographic column
containing 50 ml (2.6 cm x 9.4 cm) hydroxyapatite matrix (Macro-Prep
Ceramic Hydroxyapatite, BioRad, Munich, Germany) equilibrated with 10 mM
sodium phosphate buffer pH 7.6 containing 20 mM DTT (buffer A). The column
was washed with 250 ml buffer A and eluted stepwise with 250 ml 60 % and
250 ml 100 % of 0.4 M potassium phosphate buffer pH 7.6 (buffer C). The
fractions, corresponding to the elution with 60 % buffer C, that contained
purified TbTXNPx were pooled and stored in 50 mM sodium phosphate buffer
pH 7.6 at 4 °C.
2.6.4.3 Gel filtration chromatography on a Superdex 200
Estimation of the molecular size of the native enzyme or the intermediate (see
chapter 2.7.12) were performed by gel filtration chromatography on a
Superdex 200 HR 10/30 (Amersham Bioscience, Mannheim, Germany). High
molecular weight standard (Amersham Bioscience, Mannheim, Germany),
consisting of tyreoglobulin (699 kDa), ferritin (440 kDa), catalase (232 kDa),
aldolase (158 kDa), BSA (66 kDa) and myoglobulin (17.6 kDa), were used for
column calibration.
Reduced TbTXNPx  was chromatographed in 10 mM sodium phosphate
buffer, 20 mM DTT, pH 7.6. Eluted peroxidase was identified by activity
measurements (see chapter 2.7.10) and SDS-PAGE gel electrophoresis (see
chapter 2.5.1) under reducing and denaturating conditions.
Oxidized TbTXNPx  and intermediate (see chapter 2.7.11 and 2.7.12) were
chromatographed in 10 mM sodium phosphate buffer, pH 7.6 without DTT.
2.6.5 Cleavage of the N-terminal His-tag with thrombin
The cleavage of the N-terminal His-tag was performed with the Thrombin
Cleavage Capture Kit (Novagen, Madison, WI, USA). 1.7 U of thrombin were
used for 1 mg protein and incubated at RT overnight. After the reaction, the
biotinylated thrombin was removed by adding 16 µl strepavidin agarose per
METHODS AND MATERIALS                                                                                                                35
unit thrombin. The cleavage was confirmed by SDS-PAGE (see chapter 2.5.1),
MALDI-TOF analysis (see chapter 2.5.8) and N-terminal Edman degradation
(see chapter 2.5.7).
2.7 Analytical methods
2.7.1 Determination of TXN activity
Specific tryparedoxin activity was performed according to Nogoceke et al.
(1997) as described in detail by Flohé et al. (2002b). The test system
contained 150 µM NADPH, 1 U/ml TR, 20 µM T(SH)2, 10 µM TbH6TXNPx,
100-1500 nM TbTXNH6, up to 33 µM TbTXN-mutants, and 73 µM t-bOOH in
50 mM Tris, 1 mM EDTA pH 7.6 in a final volume of 500 µl. After preincubation
(25 °C for 15 min) the reaction was started by the addition of peroxide and the
NADPH consumption was monitored continuously at 340 nm at the Specord
2000 photometer (SAFAS, Monte Carlo, Monaco).
2.7.2 Determination of TXNPx activity
Specific tryparedoxin peroxidase activity was performed as described in
chapter 2.7.1, using 450 µM NADPH, 1 U/ml TR, 130 µM T(SH)2, 20 mM
TbH6TXN, 50 – 200 nM TbH6TXNPx and 73 µM t-bOOH in 50 mM Tris, 1 mM
EDTA pH 7.6 in a final volume of 500 µl.
2.7.3 Determination of peroxide concentration
H2O2, t-bOOH and cumene hydroperoxide were purchased from Sigma-Aldrich
(Taufenkirchen, Germany). Phosphatidyl choline hydroperoxide and linoleic
acid hydroperoxide, both prepared by soybean lipoygenase-catalyzed
oxidation of the corresponding lipids, were kindly provided by R. Brigelius-
Flohé (Potsdam, Germany). Hydroperoxide concentrations were determined
enzymatically with glutathione peroxidase (Sigma-Aldrich, Taufenkirchen,
Germany; bovine GPx-1, 0.2 mg/ml) or a phospholipid hydroperoxide
glutathione peroxidase (GPx-4) preparation of rat testis as described by Ursini
et al.(1985) and Flohé et al. (1989).
2.7.4 Determination of TXNPx activity with different peroxides
TXNPx reactivity was determined accordingly to chapter 2.7.2.
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2.7.5 Determination of glutathione peroxidase activity
The activity was investigated in a test system analogous to chapter 2.7.2
replacing TR by bakers yeast glutathione reductase (8.0 U/ml; Sigma-Aldrich,
Taufenkirchen, Germany) and trypanothione plus TXN by 3.3 mM glutathione.
After the preincubation time of 15 min at 25 °C the reaction was started by 73
µM t-bOOH.
2.7.6 Glutamine synthetase protection assay
This assay monitores the oxidative denaturation of glutamine synthetase by H2O2
generated in an aerobic solution of FeCl3 and DTT. Peroxidases, that are able to
consume H2O2, delay the process of denaturation by using DTT as an unspecific
reducing substrate. The assay contains 0.072 µg (= 0.77nM) glutamine synthetase
(GS), 10 mM DTT, 1.2 mM FeCl3, 25 µM peroxidase, and 50 mM HEPES pH 7.4 in
50 µl. Every sample was incubated for 0, 10, 20, 30 min. at 30 °C, before the
glutamine synthetase denaturation was started by adding 400 µl of GSAL (100 mM
HEPES, 0.4 mM ADP, 150 mM L-Glutamine, 10 mM potassium arsenate, 20 mM
hydroxylamine, 0.4 mM MnCl2 x 2 H2O). The mixtures were incubated for 20 min. at
37 °C and stopped with 400 µl GSSAL (0.2 M FeCl3 x 6 H2O, 0.12 M trichloric acid,
0.2 M HCl, 50 mM HEPES). The positive control contained 1 mM EDTA, instead of
peroxidase, to complex the FeCl3. The colored reaction was measured at OD540.
2.7.7 Inhibition of  TXN by bis-(ophthamyl)-spermidine
TXN activity was monitored by NADPH consumption in a reconstituted
trypanothione peroxidase system as described by Flohé et al.  (2002b). For
inhibition studies, the assay was performed in 500 µl reaction volume
containing 10 µM CfH6TXNPx or TbH6TXNPx, 225 µM NADPH (Sigma,
Taufenkirchen, Germany), 1 U/ml TR, 10 µM CfTXN2H6, CfTXN1H6 or
TbH6TXN, respectively, in 50 mM Tris, 1 mM EDTA pH 7.6, containing T(SH)2
(Bachem, Heidelberg, Germany) in concentrations of 0.6 to 1.3 µM and the
pseudosubstrate in a range from 400 to 1500 µM. The mixture was
preincubated at 25 °C for 15 minutes before the reaction was started by
adding 70 µM t-bOOH.
2.7.8 Determination of thioredoxin activity
In the test for the thioredoxin peroxidase activity TR was replaced by
thioredoxin reductase of E. coli (Sigma-Aldrich, Taufenkirchen, Germany),
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TXN by E. coli thioredoxin (Sigma-Aldrich, Taufenkirchen, Germany) and
trypanothione was omitted. The reaction was performed as described in
chapter 2.7.2.
2.7.9 Steady-state kinetic of TbH6TXNPx
The kinetic pattern of TbH6TXNPx was analyzed with TbTXNH6, in
concentrations of 0.6 µM, 0.8 µM, 1 µM, 1.3 µM and 2 µM, and t-bOOH, in a
range of 5 - 65 µM, as substrates. The concentration of TbH6TXNPx was 0.5
µM, which was chosen high enough to allow the reaction to be proceed within
less than 10 min. Under these conditions the spontaneous reaction could be
disregarded. The data thus obtained were further analyzed according to
Dalziel  (1957).
2.7.10 Preparation of reduced TbTXNPx for gel filtration
chromatography
For the estimation of the molecular size of native, reduced TbTXNPx, purified
protein was incubated with 260 mM DTT for ten minutes at room temperature
and separated on a Superdex 200 column, pre-equilibrated with 10 mM
sodium phosphate buffer, 20 mM DTT pH 7.6 (Amersham Bioscience,
Mannheim, Germany) as described in chapter 2.6.4.3.
2.7.11 Preparation of oxidized TbTXNPx for gel filtration
chromatography
For size determination of oxidized TbTXNPx, the enzyme was incubated with
300 µM t-bOOH at room temperature for 30 min in 10 mM sodium phosphate
buffer pH 7.6. The estimation of the molecular size was performed on an
equilibrated and calibrated Superdex 200 as described in chapter 2.6.4.3.
2.7.12 Purification of a dead-end intermediate by gel filtration
chromatography
A dead-end intermediate was obtained by incubating 80 µM TbTXNPx, 160
µM TbTXNC43S and 200 µM t-bOOH for 30 min at room temperature. The
reaction mixture containing an excess of TbTXNC43S was separated by gel
filtration on a Superdex 200 as described in chapter 2.6.4.3
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2.7.13 Determination of acessible reaction centers of the decameric
TbTXNPx
2.7.13.1 Determination by SDS-PAGE
The density of silver-stained bands on a 15 % SDS-gel containing different
concentrations of TbTXNPx and TbTXNC43S were compared with the density
of the bands rising from the intermediate. The gel was scanned by an
Electrophoresis Documentation and Analysis System 120 and analyzed by 1D
Image Analysis Software Windows Version 3.0 (Kodak Digital Science,
Rochester, NY, USA)
2.7.13.2 Determination by chromatography
The intermediate was reduced by 100 µM β-Mercaptoethanol, and the
tryparedoxin peroxidase was separated from the TbTXNC43S by gel
chromatography as described in chapter 2.6.4.3. Protein concentrations of the
peak areas were calculated from E280 and the respective extinction coefficients
(ε TXNC43S 280 = 0.92 mg-1 cm –1; ε TXNPx 280 = 0.42 mg-1 cm-1) calibrated by amino
acid analysis (see chapter 2.5.6).
2.8 Electron microscopic studies
Purified protein was absorbed to a carbon foil and negatively stained in 4 %
uranylacetat pH 4.5 (Valentine et al., 1968). Samples were analyzed by Dr.
Lünsdorf (GBF, Braunschweig, Germany) with an energy-filtered transmission
electron microscope (EFTEM) CEM 902 (Zeiss, Oberkochen, Germany).
Images were directly registered with a cooled 1024 x 1024 CCD-camera
(Proscan, Scheuring, Germany) and digitally optimized for sharpness and
contrast with Corel Photopaint (Corel Corporation, Ottawa, Canada).
2.9 3D-Reconstruction
For 3D-reconstruction, negatively stained TbTXNPx or TbTXNPx/TbTXNC43S
intermediate complexes were analyzed by EFTEM. The 3D-reconstruction of
the images was performed by Dr. Hecht (GBF, Braunschweig, Germany) with
the EMAN software package (Ludtke et al., 1999).
2.10  Molecular Modeling
The structural model of the intermediate was based on the coordinates of
oxidized peroxiredoxin HBP23 (Hirotsu et al., 1999) and tryparedoxin I of C.
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fasciculata (Hofmann et al., 2001). Models for the corresponding T. brucei
enzymes were generated using Modeller 6v1 (Sali and Blundell, 1993) and a
sequence alignment generated with Clustalx (Thompson et al., 1997). The
initial model of the intermediate was selected from docking calculation using
Ftdock (Gabb et al., 1997). The resulting model was manually adjusted to the
EM-based electron density using O (Jones et al., 1991). The models were
done by Dr. Hofmann (GBF, Braunschweig, Germany).
2.11  Check of protein nativity by circular dichroism
CD-spectras were recorded under N2-atmosphere at ambient temperature on a
J-600 spectropolarimeter (Jasco, Gross-Umstadt, Germany) from 260 to 180
nm. Proteins were measured at a concentration of 0.3 mg/ml in 10 mM
potassium phosphate buffer pH 7.9 in 0.5 mm Suprasil quarz cuvettes (Helma,
Jena, Germany). For every spectrum 32 single scans were recorded (401
datapoints, step resolution 0.2 nm, scan speed 10 nm/min), averaged, and the
resulting curves were smoothed using a high frequency filter and corrected for
the solvent. Secondary structure content was quantified using the program
Varselec (Manavalan and Johnson, 1987).
2.12  RNA interference
2.12.1 Cultivation of bloodstream cell line T. brucei 13-90
The bloodstream cell line 13-90 (a gift from Dr. George Cross, Rockefeller
University, New York, NY, USA) was propagated in HMI-9 completed medium
(Gibco BRL, Karlsruhe, Germany) supplemented with 10 % heat inactivated
fetal calve serum, 2.5 µg/ml neomycine, and 5 µg/ml hygromycine. Cells were
cultivated at 37 °C in 5 % CO2-atmosphere.
2.12.2 Transfection of T. brucei 13-90
The bloodstream form of T. brucei was harvested at 1400 x g at 37 °C,
washed in pre-warmed cytomix (120 mM KCl, 2 mM EGTA, 0.15 mM CaCl2,
10 mM potassium phosphate buffer pH 7.6, 25 mM HEPES, 5 mM Mg Cl2, 0.5
% glucose, 1 mM hypoxanthine) and resuspended in a concentration of 1 x 107
cells/400 µl cytomix. Transfection was performed with 10 µg NotI linearized
p2T7 plasmid DNA per cuvette, using one puls from a BTX T 820
electroporator (Qbiogene GmbH, Heidelberg, Germany) at 1.5 kV, 175 Ω, and
200 µF. After transfection cells were transferred to 50 ml HMI-9 completed
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medium and incubated over night. After 12 hours, selection was carried out by
addition of 4 µg/ml phleomycin to the medium.
2.12.3 3H-labeled thymidine incorporation
Cells containing TbTXN RNAi constructs were diluted to a final concentration
of 1 x 105 cells/ml. 3H-labeled thymidine was added to the medium of an
uninduced culture and a culture, induced with 1 µg/ml tetracycline, in a
concentration of 5 µCi/ml. After 0, 8, 24, 32 and 48 hours 1 ml of culture was
pelleted at 20,000 x g and washed with TDB (5 mM KCl, 80 mM NaCl, 1 mM
MgSO4, 20 mM Na2HPO4, 2 mM NaH2PO4, 20 mM glucose). Proteins were
precipitated by adding 5 % TCA for 10 min. The DNA was washed with H2O
and resuspended in 0.3 M NaOH and added to 2.5 ml ECO Plus (Rotiszint
ECO plus, Roth, Karlsruhe, Germany). The solution was incubated over night
and the incorporated 3H-labeled thymidine was measured by a β-counter (LS
6500, Beckmann, Würzburg, Germany).
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3 Results
3.1 The T. brucei brucei peroxidase system
3.1.1 Preparation of the system components
The system components to be studied, TbTXN and TbTXNPx, were obtained
by heterologous expression of the pertinent genes in E. coli BL21(DE3) or
Tuner(DE3). The gene of TXN of T. brucei brucei (Acc.No. AJ006403) had
before been identified by Lüdemann et al. (1998) and could easily be obtained
by PCR. The gene was cloned and expressed in the pET28c(+) vector to yield
a protein with an N-terminal His-tag (TbH6TXN) or in the pET22b(+) vector to
yield a C-terminal His-tagged protein (see chapter 2.6.2). A considerable
proportion of the expression product was initially found in the pellet, but with
progressing time after induction sufficient amounts appeared in the soluble
fraction to disregard the insoluble part (see Figure 3.1).
  1      2      3     4    5      6      7       8     9    10    11
lane number
10kDa
20kDa
30kDa
50kDa
TbTXNH6
Figure 3.1: The synthesis of TbTXNH6 in E. coli BL21(DE3) transfected with
recombinant pET22b(+) upon induction by 1 mM IPTG, analyzed by SDS-PAGE, is
shown. lane 1: molecular weight marker (MBI Fermentas, St. Leon-Roth, Germany);
lane 2 and 3: cell pellet and supernatant before induction; lane 4 and 5: cell pellet and
supernatant one hour after induction with 1 mM IPTG; lane 6 and 7: 2 hours after
induction; lane 8 and 9: 3 hours after induction; lane 10 and 11: four hours after
induction.
The expression products were isolated by His-bind chelate chromatography
(see chapter 2.6.4.1). The N-terminal His-tag was removed by thrombin at a
single cleavage site located between the His-tag and the genuine TbTXN
sequence, leaving three amino acids at the N-terminus (Gly-Ser-His). Product
identity was confirmed by MALDI-TOF analysis and Edman degradation. The
homogenous protein thus obtained and certificated had the expected size of
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18,053 Da for the TbH6TXN and 16,282 Da for the TbTXN cleaved with
thrombin (see Figure 3.2).
1       2       3
15 kDa
20 kDa
25 kDa
TbTXN
TbH6TXN
lane number
Figure 3.2: TbH6TXN and TbTXN after chelate chromatography on a His-bind column.
lane 1: molecular weight marker (MBI Fermentas, St. Leon-Roth, Germany) lane 2:
purified TbH6TXN; lane 3: purified TbTXN after thrombin cleavage.
The ability to substitute for TXN of Crithidia fasciculata in a reconstituted
trypanothione peroxidase system, first established by Nogoceke et al. (1997),
proved nativity of TbH6TXN (not shown). Molecular mutants (see below) were
obtained accordingly.
The gene encoding TXNPx in T. brucei brucei was unknown, but could be
anticipated to be closely related to a DNA sequence of T. brucei rhodesiense
proposed to encode an “antioxidant protein” (el-Sayed et al., 1995). With
primers designed accordingly (see chapter 2.4.4) a full-length coding
sequence was obtained from the genomic DNA of T. brucei brucei that was
identical, except for primer-independent amino acid residues at least, with the
T. brucei rhodesiense homologue (see Figure 3.3). The amino acid sequence
showed typical characteristics of a tryparedoxin peroxidase and displayed high
similarity to TXNPx of Leishmania donovani (LdTXNPx), Leishmania major
(LmTXNPx), Trypanosoma cruzi (TcTXNPx), and Crithidia fasciculata
(CfTXNPx). With 199 residues TbTXNPx corresponds precisely to the
cytosolic TXNPxs of L. donovani, T. cruzi and L. major, which are slightly
longer than that of C. fasciculata, but markedly shorter than the putative
mitochondrial variants of T. brucei brucei, T. cruzi or L. infantum (see Figure
3.3).
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                 1                                               50
   
TbrTSA    (1) ------------------------------MSCGDAKLNHPAPHFNEVAL
  
TbTXNPx    (1) ------------------------------MSCGDAKLNHPAPHFNEVAL
  
CfTXNPx    (1) ------------------------------MSCGAAKLNHPAPEFDDMAL
  
LdTXNPx    (1) ------------------------------MSCGNAKINCPAPPFEEVAL
  
LiTXNPx    (1) ------------------------------MSCGDAKINCPAPPFEEVAL
  
LmTXNPx    (1) ------------------------------MSCGNAKINSPAPSFEEVAL
  
TcTXNPx    (1) ------------------------------MSCGDAKLNHPAPDFNETAL
 
LimTXNPx    (1) MLRRLPTSCFLKRSQFRGFAATSPLLNLDYQMYRTATVREAAPQFSGQAV
 
TbmTXNPx    (1) MLRRFSMLPLSGGIARRSFFRTAPLFNLDYQAYRTATVREAAPEFAGKAV
 
TcmTXNPx    (1) MFRRMAVTSLQKGLSRRAFCNTLRLLNLDYQAYKTATVREAAPEWAGKAV
                 51                                             100
   
TbrTSA   (21) MPNGTFKKVDLASYRGKWVVLFFYPLDFTFVCPTEICQFSDRVKEFNDVD
  
TbTXNPx   (21) MPNGTFKKVDLASYRGKWVVLFFYPLDFTFVCPTEICQFSDRVKEFNDVD
  
CfTXNPx   (21) MPNGTFKKVSLSSYKGKYVVLFFYPMDFTFVCPTEIIQFSDDAKRFAEIN
  
LdTXNPx   (21) MPNGSFKKISLAAYKGKWVVLFFYPLDFTFVCPTEIIAFSENVSRFNELN
  
LiTXNPx   (21) MPNGSFKKISLAAYKGKWVVLFFYPLDFTFVCPTEIIAFSENVSRFNELN
  
LmTXNPx   (21) MPNGSFKKISLSSYKGKWVVLFFYPLDFTFVCPTEVIAFSDSVSRFNELN
  
TcTXNPx   (21) MPNGTFKKVALTSYKGKWLVLFFYPMDFTFVCPTEICQFSDRVKEFSDIG
 
LimTXNPx   (51) VN-GAIKDINMNDYKGKYIVLFFYPMDFTFVCPTEIIAFSDRHADFEKLN
 
TbmTXNPx   (51) VD-GKIKDISMNDYKGKYIVLFFYPLDFTFVCPTEIVSFSDSHAEFEKLN
 
TcmTXNPx   (51) VN-GKIQDISLNDYKGKYVVLLFYPMDFTFVCPTEITAFSDAQAEFDKIN
                 101                                            150
   
TbrTSA   (71) CEVIACSMDSEFSHLAWTNVERKKGGLGTMNIPILADKTKSIMKAYGVLK
  
TbTXNPx   (71) CEVIACSMDSEFSHLAWTNVERKKGGLGTMNIPILADKTKSIMKAYGVLK
  
CfTXNPx   (71) TEVISCSCDSEYSHLQWTSVDRKKGGLGPMAIPMLADKTKGIARAYGVLD
  
LdTXNPx   (71) CEVLACSMDSEYAHLQWTLQDRKKGGLGAMAIPMLADKTKSIARAYGVLE
  
LiTXNPx   (71) CEVLACSMDSEYAHLQWTLQDRKKGGLGAMAIPMLADKTKSIARAYGVLA
  
LmTXNPx   (71) CEVLACSIDSEYAHLQWTLQDRKKGGLGTMAIPMLADKTKSIARSYGVLE
  
TcTXNPx   (71) CEVLACSMDSEYSHLAWTSIERKRGGLGQMNIPILADKTKCIMKSYGVLK
 
LimTXNPx  (100) TQVVAVSCDSVYSHLAWVNTPRKKGGLGEMHIPVLADKSMEIARDYGVLI
 
TbmTXNPx  (100) TQVIAVSCDSHFSHLAWVETPRKKGGLGEMKIPLLSDFTKEISRDYGVLV
 
TcmTXNPx  (100) TQVVAVSCDSQYSHLAWINTPRNKGGLGEMSIPVLSDLTKEIARDYGVLI
                 151                                            200
   
TbrTSA  (121) EEDGVAYRGLFIIDPQQNLRQITINDLPVGRNVDETLRLVKAFQFVEKHG
  
TbTXNPx  (121) EEDGVAYRGLFIIDPQQNLRQITINDLPVGRNVDETLRLVKAFQFVEKHG
  
CfTXNPx  (121) EDSGVAYRGVFIIDPNGKLRQIIINDMPIGRNVEEVIRLVEALQFVEEHG
  
LdTXNPx  (121) EKQGVAYRGLFIIDPNGMVRQITVNDMPVGRNVEEVLRLLEAFQFVEKHG
  
LiTXNPx  (121) EKQGVAYRGLFIIDPNGMVRQITVNDMPVGRNVEEVLRLLEAFQFVEKHG
  
LmTXNPx  (121) ESRGVAYRGLFIIDPHGMLRQITVNDMPVGRSVEEVLRLLEAFQFVEKHG
  
TcTXNPx  (121) EEDGVAYRGLFIIDPKQNLRQITVNDLPVGRDVDEALRLVKAFQFVEKHG
 
LimTXNPx  (150) EESGIALRGLFIIDKKGILRHSTINDLPVGRNVDEALRVLEAFQYADENG
 
TbmTXNPx  (150) EEQGLSLRALFVIDDKGILRHVTINDLPVGRNVDEVLRVVQAFQYADKTG
 
TcmTXNPx  (150) EEQGISLRGLFIIDDKGILRHITVNDLPVGRNVEEVLRVVQAFQYVDKNG
                 201                         231
   
TbrTSA  (171) EVCPANWKPGSKTMKADPNGS-QDYFSSMN-
  
TbTXNPx  (171) EVCPANWKPGSKTMKADPNGS-QDYFSSMN-
  
CfTXNPx  (171) EVCPANWKKGDAKKK-------EGH------
  
LdTXNPx  (171) EVCPANWKKGAPTMKPEPKASVEGYFSKQ--
  
LiTXNPx  (171) EVCPANWKKGAPTMKPEPKASVEGYFSKQ--
  
LmTXNPx  (171) EVCPANWKKGAPTMKPEPKASVEGYFSKQ--
  
TcTXNPx  (171) EVCPANWKPGDKTMKPDPEKS-KEYFGAVA-
 
LimTXNPx  (200) DAIPCGWKPGQPTLDTTKAG---EFFEKNM-
 
TbmTXNPx  (200) DVIPCNWKPGKETMKVEAAK---EYFEKNL-
 
TcmTXNPx  (200) DVIPCNWRPGKPTMKTEKAN---EYFEKNA-
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Figure 3.3: Alignment of the “thiol specific antioxidant” protein from T. brucei
rhodesiense (TbrTSA acc. No. U26666.1) and tryparedoxin peroxidase of T. brucei
brucei (TbTXNPx acc. No. AF283104) with known tryparedoxin peroxidases.
Conserved residues are shown in red and the active site cysteines embedded in the
VCP or IPC, in the cases of mitochondrial TXNPxs, motifs are shown in yellow. Those
conserved in one or more subfamilies are colored and not conserved residues are
shown in black. CfTXNPx, C. fasciculata TXNPx (acc. No. AF020947); LdTXNPx, L.
donovani TXNPx (acc. No. AF225212), LiTXNPx, L. infantum TXNPx (acc. No.
AY058210); LmTXNPx; L. major TXNPx (acc. No. AF069386); TcTXNPx, T. cruzi TXNPx
(acc. No. CAA09922); LimTXNPx, mitochondrial TXNPx of L. infantum (acc. No.
AY058209); TbmTXNPx, mitochondrial TXNPx of T. brucei brucei (acc. No. AF196570);
TcmTXNPx, mitochondrial TXNPx of T. cruzi (acc. No. AJ006226)
Like all  known cytosolic TXNPx species the TbTXNPx contains two conserved
cysteines (C52 and C173) each embedded in a Val-Cys-Pro (VCP) motif,
which differs from Ile-Pro-Cys (IPC) motif that composes the conserved
second cysteine of mitochondrial TXNPxs.
Expression was achieved with different pET vectors, pET24a(+) yielding the
unmodified protein (TbTXNPx)(see Figure 3.4), pET22b(+) designed to add a
C-terminal His-tag (TbTXNPxH6) and pET28c(+) resulting an N-terminal His-
tag (TbH6TXNPx) (see Figure 3.4).
10kDa
20kDa
50kDa
30kDa
TbTXNPx
lane number
1        2        3       4      5        6      7      8        9      10    11
Figure 3.4: Expression pattern of the unmodified TbTXNPx. lane 1: molecular weight
marker (MBI Fermentas, St. Leon Roth, Germany); lane 2 and 3: cell pellet and
supernatant before induction; lane 4 and 5: cell pellet and supernatant one hour after
induction with 1 mM IPTG; lane 6 and 7: cell pellet and supernatant two hours after
induction; lane 8 and 9: cell pellet and supernatant three hours after induction; lane 10
and 11: cell pellet and supernatant four hours after induction.
TbH6TXNPx was primarily found in the soluble fraction and could be purified in
one step by chelate chromatography. Removal of the His-tag in TbH6TXNPx
by thrombin proved to be impossible likely due to inaccessibility of the
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cleavage site in the oligomeric protein. Therefore the unmodified protein,
TbTXNPx, was purified by chromatographic techniques that had been
successfully applied to the purification of authentic TXNPx from C. fasciculata
(Nogoceke et al., 1997). N-terminal Edman degradation complied with the
expected sequence up to position 22. Confirmation of the right size was done
by MALDI-TOF analysis, 24,698 Da for TbH6TXNPx, 22,534 Da for the
unmodified TbTXNPx and 23,599 Da for the C-terminally His-tagged protein
TbTXNPxH6, as well as by SDS gel electrophoresis and Western blot analysis
with anti CfTXNPx antibodies (see Figure 3.5).
50 kDa
Tb
1         2          3              4        5
lane number
Tb
20 kDa
monomeric TXNPx
dimeric TXNPx
Figure 3.5: Purified TbTXNPx as monomer and dimer verified by Western Blot. lane 1:
molecular weight marker (MBI Fermentas, St. Leon-Roth, Germany); lane 2 and 3:
Coomassie stained TbTXNPx; lane 4 and 5: Western blot of TbTXNPx with rabbit anti
CfTXNPx antibodies.
After purification, both, TbTXNPx and TbH6TXNPx, proved to be active
tryparedoxin peroxidases with TXNs from different species, while TbTXNPxH6
was completely inactive (data not shown). The specific TXNPx activity, when
analyzed by our routine procedure (see chapter 2.7.2) with tertiary-butyl-
hydroperoxide (t-bOOH), was 17 ± 0.8 U/mg for TbH6TXNPx and 9 ± 1.6
U/mg for TbTXNPx. These values lie in the same order of magnitude as those
of authentic CfTXNPx (Nogoceke et al., 1997), CfTXNPxH6 (Montemartini et
al., 1998b), and TcTXNPx (Guerrero et al., 2000a).
3.1.2 Basic characteristics of TbH6TXNPx
The tryparedoxin peroxidase nature of the T. brucei peroxiredoxin is
underscored by its specificity for the homologous TbTXNH6 as reductant. As
Kinetoplastida also contain typical thioredoxins (Reckenfelderbäumer et al.,
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2000), analogous experiments were performed offering up to 5.9 µM
thioredoxin of E. coli as reducing substrate. TbH6TXNPx proved to catalyze
the reaction between the thioredoxin of E. coli and t-bOOH, that is due to the
similarity of active site motif (CXXC). T(SH)2 or glutathione did not yield any
measurable activity with TbH6TXNPx (see Table 3.1).
Enzyme Reductants spec. act. (%)
TbTXNPx TR/T(SH)2/TXN (100)
TbTXNPx TrxR/Trx 19
TbTXNPx GR/GSH 0
Table 3.1: Relative activities of TXNPx for different thiol substrates. TR, trypanothione
reductase of T. cruzi; T(SH)2, trypanothione (Bachem, Weil am Rhein, Germany); TXN,
TbTXNH6 of T. brucei; TrxR, thioredoxin reductase of E. coli; Trx, thioredoxin of E.
coli; GR, glutathione reductase of E. coli; GSH, glutathione.
The substrate t-bOOH is conveniently used to characterize TXNPx, because
its spontaneous reaction with trypanothione and tryparedoxin is slow enough
to be ignored in most experimental settings. With TbH6TXNPx it does not
react as fast as the predominant natural substrate H2O2. Like TXNPxs from
other species, TbH6TXNPx proved to be a broad-spectrum peroxidase acting
with H2O2 and organic hydroperoxides including complex lipid hydroperoxides
(see Table 3.2). Cumene hydroperoxide, frequently used as a model for
natural lipophilic hydroperoxides, is also reduced by TbH6TXNPx. But
naturally occurring lipid hydroperoxides such as 13-hydroperoxy
octodecadienoic acid (LOOH) and soybean lipoxygenase-peroxidized
phosphatidyl choline (PCOOH) are accepted with much lower rates and, like
with LimTXNPx and LdTXNPx, fast inactivation by these substrates could be
observed (Castro et al., 2002a; Flohé et al., 2002a). The relative specific
activities for the lipid hydroperoxides listed in Table 3.2 correspond to initial
velocities measured at the highest enzyme concentrations that could
technically be monitored.
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Enzyme t-bOOH LOOH PCOOH H2O2 COOH Reference
TbH6TXNPx 100 10.4* 1.7* 140 45*
CfTXNPx 100 43 19 43 n.d. Nogoceke et al., 1997
LmH6TXNPx 100 n.d. n.d. 459 0 Levick et al., 1998
LimH6TXNPx 100 8.4* 4.0* 105 60 Castro et al., 2002a
LdH6TXNPx 100 18 3.3* 209 97 Flohé et al., 2002a
Table 3.2: Relative specificity of TbH6TXNPx with different peroxides as substrates.
The activities with t-butyl hydroperoxide (t-bOOH) were set to 100 %. LOOH, PCOOH,
and COOH mean linoleic acid hydroperoxide, phosphatidyl cholin hydroperoxide and
cumene hydroperoxide, respectively. Specificities reported for TXNPxs of other
species are added for comparison. Cf, C. fasciculata; Lm, L. major; Ld, L. donovani; Li,
L. infantum. * Means fast inactivation by substrate.
3.1.3 Steady-state kinetics of T. brucei TXNPx
Based on extensive studies on TXNPxs of other species (Nogoceke et al.,
1997; Guerrero et al., 2000a; Flohé et al., 2002a) and related 2-Cys-
peroxiredoxins (Baker et al., 2001), a “ping-pong” or “enzyme substitution”
mechanism was expected. The kinetic pattern of these enzymes observed in
steady-state-kinetic analysis complied with the general Dalziel equation of a
two-substrate reaction (Dalziel, 1957), wherein the term Φ1,2/[A] [B] was zero.
[E0]
v Φ0
Φ1 Φ2
[A] 
Φ1,2
[B] [A] [B]++
+=
Equation 3.1: Dalziel equation for a two-substrate reaction. [E0] is the total enzyme
concentration; v the initial velocity at pertinent substrate concentration [A] and [B]
and Φ0, Φ1, Φ2, and Φ1,2 are kinetic coefficients characterizing a particular enzyme.
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In view of experimental difficulties in obtaining reliable initial velocities for the
reduction of natural lipid hydroperoxides, the kinetic behavior of TbH6TXNPx
was only investigated with the most convenient substrate, t-bOOH, which was
shown not to inactivate the enzyme within 20 minutes. As an additional
measure of precaution, the enzyme concentration was chosen high enough to
allow completion of the reaction within less than 10 min.
A ping-pong pattern, similar to previous investigations on related enzymes
(Nogoceke et al., 1997; Guerrero et al., 2000a; Baker et al., 2001; Flohé et al.,
2002a), could be expected from the type of catalysis (Hofmann et al., 2002). In
that case the term Φ1,2/[A] [B], that characterizes a central complex
mechanism, should be zero. The kinetic analysis of TbH6TXNPx surprised
with irregularities similar to those that had previously been observed with a
mitochondrial TXNPx of L. infantum (Castro et al., 2002a). The primary Dalziel
plot, that shows the reciprocal hydroperoxide concentration at different fixed
TXN concentrations, does neither yield linear slopes nor can the slopes
measured at different cosubstrate concentrations be rated to be strictly
parallel. The set of data was obtained by single curve progression analysis.
Initial velocities were read from the substrate consumption curves that
correspond to 12 residual substrate concentrations giving distant abscissa
points in the double reciprocal plot. Thereby a balanced and unibased
statistical weight of the individual velocities over a substrate range between 95
% and 5 % of the starting concentration was to be guaranteed. A minimum of
three data sets were generated.
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Figure 3.6: Steady-state kinetics of TbH6TXNPx. Substrate turnover by TbH6TXNPx
was monitored continuously by NADPH consumption in a coupled test system as
described in chapter 2.7.9 at 25 °C and pH 7.6 with t-bOOH as substrate and TbTXNH6
as cosubstrate. Three sets of data were analyzed according to Dalziel (1957). Example
of primary Dalziel plot showing enzyme normalized inverse initial velocities ([E0]/v) in
dependence of reciprocal hydroperoxide concentrations at different TbTXNH6
concentrations that were kept constant by continuous regeneration. Note the biphasic
slopes; only the flatter parts were used for data processing.
As is at least evident from the upper curves in Figure 3.6, the slopes are
clearly biphasic being steeper at high hydroperoxide concentrations.
Qualitatively, the same phenomenon is seen in the curves obtained at higher
TXN concentrations. Unfortunately, the two phases of the curves could not be
assessed with the same accuracy for technical reasons. Only the flatter
slopes, that are observed over a wide range of lower peroxide concentrations,
could be used for further data processing such as the calculations of the
Dalziel coefficients and the kinetic constants. Replotting the ordinate intercepts
of the Dalziel primary plot (the reciprocal enzyme-normalized apparent
maximum velocities for infinite concentrations of t-bOOH = [A]) against the
reciprocal concentrations of cosubstrate TbTXNH6 (=[B]) yields Φ0 as ordinate
intercepts and Φ2 being the slope of the secondary plot (see Figure 3.7).
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Figure 3.7: Secondary plot of ordinate intercepts ([E0]/Vapp.) of the primary plots
against reciprocal cosubstrate (TbTXNH6) concentrations.
As the regression lines in the primary plot of TbH6TXNPx converge and are
not parallel as expected, the term Φ1,2/[A] [B] is different from zero, which is
highly unusual for a peroxidase (Flohé and Brigelius-Flohé, 2001). The
coefficients Φ1 and Φ1,2 are obtained by replotting the slopes of the primary
plots against 1/[TbTXNH6] as ordinate intercepts and slope, respectively (see
Figure 3.8).
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Figure 3.8: Tertiary Dalziel plot of averaged slopes (Φ1app.) of primary plots versus
reciprocal cosubstrate concentration (TbTXNH6).
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The Dalziel coefficients and kinetic constants, as obtained from the Dalziel
plots are compiled in Table 3.3.
Enzyme
Φ0
[s]
Φ1
[s µM]
Φ2
[s µM]
Φ1,2
[s µM2]
KM ROOH
[µM]
KM TXN
[µM]
kcat.
[s-1]
Reference
CfTXNPx 0 5.3 0.51 0 ∞ ∞* ∞
Nogoceke et
al., 1997
TcTXNPxH6 0.60 30.9 1.0 0 51.8 1.66# 1.7
Guerrero et
al., 2000
LdH6TXNPx 0.14 4.2 0.48 0 30.5 3.4* 7.2
Flohé et al.,
2002a
LiH6mTXNPx 0.03 0.26 0.85 0.83 9.15 31.90# 33.3
Castro et al.,
2002a
TbH6TXNPx 0.20 0.06 0.93 1.49 0.28 4.64x 5.0
Table 3.3: Dalziel coefficients and kinetic constants of TbH6TXNPx compared with
TXNPxs of other species. Cf, C. fasciculata; Tc, T. cruzi; Ld, L. donovani; Lim,
mitochondrial TXNPx of L. infantum. * TXN is CfTXN1H6; # TXN is CfTXN2H6; x TXN is
TbH6TXN.
Compared with other TXNPxs, TbH6TXNPx appears to be an unusually active
peroxiredoxin-type peroxidase. The extrapolated Φ1 is comparatively low
which implies that the reaction constant k´1 for the reaction of the reduced
enzyme with the peroxide is accordingly high, since by definition Φ1 equals
1/k´1. The value of the net forward rate constant for TbH6TXNPx corresponds
with the values obtained from the selenium-containing glutathione peroxidases
of mammals (Flohé and Brigelius-Flohé, 2001). The steep parts of the slopes
of the primary plot (see Figure 3.6) could be taken as a very rough
approximation for the Φ1 values resulting from a conformation change of the
enzyme due to strongly oxidizing conditions. They would indicate a very low
k´1. This could be interpreted to result from impaired accessibility of the
reaction center to the hydroperoxide. The reciprocal value of the extrapolated
Φ2 can only describe the reaction constant  for the reaction of the oxidized
TXNPx with the cosubstrate TXN. Φ0 is defined as the reciprocal value of the
velocity at infinite concentrations of both substrates, t-bOOH and TXN, that
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means kcat. A finite kcat is not uncommon for peroxiredoxins (Montemartini et
al., 1999; Guerrero et al., 2000a; Flohé et al., 2002a). The meaning of Φ1,2
remains elusive. In a central complex mechanism both substrates are bound to
the enzyme to build a ternary complex and Φ1,2 is the coefficient related to this
process. Since such complex mechanisms can be ruled out for 2-Cys-
peroxiredoxins in general, it may be guessed that here Φ1,2 reflects substrate-
induced conformational changes that modulate the affinity to the cosubstrate.
3.1.4 Reaction mechanism of TXNPx
Like most peroxiredoxins, TXNPx possesses a reactive cysteine residue in its
N-terminal domain, which is imbedded in a VCP motif (C52) and repeated in
its C-terminal domain (C173) (see Figure 3.3). As has become evident from
structural data (Hirotsu et al., 1999; Alphey et al., 2000), the C52 builds a
disulfide bridge to C173´ of a second subunit. Two possible reaction centers
are build by two subunits within the homooligomeric enzyme. The reducing
thiol substrate, here reduced tryparedoxin, then attacks the disulfide bond at
the C173, with its only solvent exposed Cys40 of the active site, and the
catalysis can proceed (as outlined in Figure 3.9).
E EA F
Figure 3.9: Scheme of the reaction mechanism of TXNPx. TXN, tryparedoxin; ROOH,
hydroperoxide; ROH, alcohol; E, ground state enzyme; F, G, and H, catalytic
intermediates; P1 and P2, first and second subunit of the dimeric protein. The
sulfhydryl group of Cys40 in TbTXN is shown to be dissociated (B) to emphasize its
presumed nucleophilic attack on the disulfide bridge of oxidized TXNPx. Identical
reactions may occur within the second pair of SH groups of the intersubunit active
site (not shown) (Flohé et al., 2002b; Hofmann et al., 2002)
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The present view of the catalytic cycle, as illustrated in Figure 3.9, was
originally deduced from previous investigations of the homologous yeast
thioredoxin peroxidase (Chae et al., 1994b) and the first established X-ray
structure of a peroxiredoxin, that of human ORF6 (Choi et al., 1998), now
reclassified as a non-selenium glutathione peroxidase.
3.1.4.1 Necessity of conserved cysteines
The proposed reaction mechanism of 2-Cys-peroxiredoxins is supported by
experimental evidence. The TXNPxs of Kinetoplastida decreased or abolished
dramatically their specific activity when the distal conserved cysteine was
changed to a serine (see Table 3.4).
Data relevant to reacting cysteines
Peroxidase Reductant
Relative activity (%)
CfTXNPx CfTXN2 (100)
CfTXNPxC52SH6 CfTXN2 0
CfTXNPxC173SH6 CfTXN2 4.2
LdH6TNPx CfTXN2H6 (100)
LdH6TXNPxC52S CfTXN2H6 0
LdH6TXNPxC173S CfTXN2H6 0.02
TbH6TXNPx TbH6TXN (100)
TbH6TXNPxC52S TbH6TXN 0
TbH6TXNPxC173S TbH6TXN 5.2
Table 3.4: Exchange of the two conserved active site cysteines of TXNPx by serine of
Cf, C. fasciculata (Montemartini et al., 1999); Ld, L. donovani (Flohé et al., 2002a), and
Tb, T. brucei (Budde et al., 2003a).
Exchange of the C52 versus serine abolishes the activity in  C. fasciculata, L.
donovani and T. brucei completely, while a marginal activity is left when the
C173 is mutated. The view that the C52 is the residue that is oxidized by the
peroxide substrate is supported by the findings that the C173S muteins of L.
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donovani TXNPx (Flohé et al., 2002a) and TrxPx of Saccharomyces cerevisiae
(Chae et al., 1993), retained activity in the glutamine synthetase protection
assay and the C52S muteins did not (see chapter 3.2.2). The conclusion is
further provided by molecular models based on homology considerations and
site-directed mutagenesis. The mutagenesis studies on C. fasciculata
(Montemartini et al., 1999) and L. donovani (Flohé et al., 2002a) proved, that
the residues R128 and T49 are essential for activity. The catalytic triad
activates the thiol in the proximal domain of TXNPx. (Flohé et al., 2002a;
Hofmann et al., 2002) (see Figure 3.10).
Figure 3.10: Modeling of the catalytic cycle of TXNPx. In the reduced TXNPx the sulfur
of C52 in the center of the catalytic triad is activated by R128 and T49 (left panel).
Upon oxidation C52 reacts with C173´ of a second inverted subunit to form a disulfide
bond in the intersubunit active site (right panel).
3.1.4.2 Oligomeric nature of TXNPx
Although a peroxiredoxin dimer theoretically forms a functional unit, higher
aggregates appear to be preferred. The crystal structures of three 2-Cys-
peroxiredoxins have revealed decameric forms, built of five homodimers: the
reduced tryparedoxin peroxidase from C. fasciculata (Alphey et al., 1999b), the
thioredoxin peroxidase B from human erythrocytes (Schröder et al., 2000) and
the oxidized form of alkyl hydroperoxide reductase from S. typhimurium (Wood
et al., 2002). Normally the dimeric form of peroxiredoxins tend to be inactive as
observed with TXNPx of C. fasciculata, when diluted (Flohé et al., 2002b).
Exception are the AhpCs of S. typhimurium (Wood et al., 2002) and M.
RESULTS                                                                                                                                          55
tuberculosis (T. Jäger, unpublished data), because they tend to form active
dimers when oxidized and decamers in the reduced state.
Therefore the molecular weight of TbTXNPx and the influence of the redox
state on the molecular weight were investigated.
As commonly observed with 2-Cys-peroxiredoxins, a trace of dimeric
TbTXNPx was always detectable in SDS gels under reducing conditions (see
Figure 3.5). The major band appeared at the molecular mass corresponding to
one subunit (TbTXNPx = 22,507 Da). The denaturating conditions of the SDS-
PAGE and boiling for 10 min at 95 °C were not able to abrogate the
dimer/dimer interactions of the oligomeric protein completely.
MALDI-TOF analysis of a freshly prepared TbH6TXNPx gave a spectrum with
mass peaks corresponding up to octamers that disclosed an unusually high
affinity of the dimers to each other (see Figure 3.11). The dimer peak was
most prominent, while the peak corresponding to the subunit size was small
and could also represent a double charged dimer.
Figure 3.11: MALDI-TOF analysis of TbH6TXNPx. The highest peak corresponds to the
dimeric state and all even subunit multimers (tetra-, hexa-, and octamer peaks) appear
substantially higher than that of the uneven numbers.
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It is surprising that this non-covalent dimer/dimer interaction is evidently strong
enough to resist laser desorption and ionization.
3.1.4.3 Influence of the redox-status on the molecular weight of TbTXNPx
For studies of the influence of the redox-state on the molecular weight of the
enzyme, reduced and oxidized TbTXNPx were subjected to a Superdex 200
column for gel permeation. The effluents were analyzed for specific activity by
the conventional assay (see chapter 2.7.2), for identity by SDS gel
electrophoresis, and for the shape by electron microscopy.
The reduced protein seemed to elute homogeneously in a single peak (E280),
with paralleling activity. The peak fraction eluted with an apparent molecular
weight of 236,400 Da that complies with the decamer size of TbTXNPx
(225,507 Da). The corresponding  silver-stained SDS-gel displayed a major
band corresponding to the subunit size of TbTXNPx with a trace of dimer.
Surprisingly the electron micrographs showed a non-homogenous fraction
consisting of ring-shaped and pearl-chain-like structures (see Figure 3.12 A,
middle panel). The ring-shaped structures were considered to represent the
pentamers of dimers that were anticipated from X-ray crystalography of
CfTXNPx (Alphey et al., 2000) or by electron microscopy for human TrxPx
(Harris et al., 2001) and LimTXNPx (Castro et al., 2002a).
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Figure 3.12: Status of oligomerization of reduced and oxidized TbTXNPx. (A) The
upper panel shows the elution profile of DTT-reduced TbTXNPx in terms of
proteinconcentration (E280, solid line) and activity (U/ml, solid line with black dots). In
the middle panel the appearance of the peak fraction in electron microscopy
(uranylacetate-stained) is shown. Notice the mix of rings (black arrow) and open-chain
structures. The lower part demonstrates the appearance of individual fractions in SDS-
PAGE. (B) Same as (A) but oxidized with t-bOOH. The smaller SDS-bands co-eluting
with TbTXNPx are likely truncated forms thereof, as indicated by N-terminal
sequencing. Also traces of dimers could be detected. The ring-shaped structure is
indicated by a black arrow.
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The oxidized enzyme (see Figure 3.12 B) eluted with a different pattern. The
front peak eluted with the exclusion volume of the column, followed by a small
shoulder and a discrete peak with a molecular weight similar to that of the
reduced enzyme. All fractions showed activity, but the highest was measured
in the fractions corresponding to the last peak. In the SDS gel the subunit band
and an increase of the dimer with progressing retardation on the column was
seen. Electron-microscopy revealed that the front peak consisted of highly
aggregated material without any detectable structures (not shown). The
shoulder contained clusters of discrete structural elements the nature of which
became evident when inspecting the late peak material. Here isolated ring-
shaped structure prevailed which were hardly distinguishable from those seen
in the preparation of the reduced enzyme. Rarely side views of piled-up rings
are seen. Open chain structures indicating sizes lower than decamers could
not be detected. Higher order multimers, stacking into columns of various
lengths could also be detected for mammalian PrxII (Harris et al., 2001) and
PrxIII (Kato et al., 1985) which are typical 2-Cys-peroxiredoxins. In conclusion,
the redox status of TbTXNPx effects the dimer/dimer interaction. The tendency
to form decameric rings is weakened by reduction and strengthened by
oxidation. The oxidized enzyme also trends to form higher aggregates of
decamers, which is accompanied by a decline in specific activity.
3.1.5 TXNPx/TXN interaction
TXNs may systemically be described as trypanothione:protein disulfide
oxidoreductases. In the context of trypanosomal peroxide metabolism the
disulfide substrate is the peroxiredoxin-type TXNPx. Beside their function as
reducing equivalent to ribonucleotide reductase (Dormeyer et al., 2001), they
are the substrates of TXNPx. TXNs appear to be specifically reduced by
T(SH)2, as GSH and thioredoxins are poor substrates (see chapter 3.1.2)
(Gommel et al., 1997; Nogoceke et al., 1997; Steinert et al., 2000; Castro et
al., 2002a). The molecular basis of this specificity has become evident from
molecular modeling (Hofmann et al., 2001), site-directed mutagenesis
(Steinert et al., 2000; Hofmann et al., 2001), and X-ray crystallography (Alphey
et al., 1999a; Hofmann et al., 2001).
As discussed above (see chapter 3.1.4), TXNPx is an oligomeric enzyme and
builds-up the reaction centers between two subunits. The conserved C52
residue is first oxidized by H2O2 to a sulfenic acid derivative (see Figure 3.9;
intermediate F) and reacts with the conserved C173´ of a second invertedly
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orientated subunit  to build a intersubunit disulfide bridge (see Figure 3.9,
intermediate G). The formation of the disulfide bridge is associated with
considerable conformational changes that lead to exposure of the C173´ to the
surface. Since the C40 of TbTXN is the only accessible one from the solvent
side, it attacks the disulfide bond of the oxidized TbTXNPx resulting in an
intermediate formation. The intermediate-state is resolved by formation of an
intramolecular disulfide bridge between C40 and C43 of the tryparedoxin
active site motif (WCPPCR), and an oxidized tryparedoxin and a reduced
tryparedoxin peroxidase are released.
Figure 3.13: Model of the catalytic intermediate demonstrating potential TXNPx/TXN
interactions. Docking of reduced TbTXN (grey ribbon model) to oxidized TbTXNPx
(brown ribbon diagram subunit 1, black ribbon diagram subunit 2) suggests a
nucleophilic attack of C40 of TXN on C173´ of the TXNPx that is facilitated by four
ionic attractions (left panel). The resulting intermediate is devoid of sterical
infringements and appears stabilized by multiple electrostatic attractions between
TXNPx (ribbon diagram, residue names shown in red) and TXN [surface charges
shown in red (negative) and blue (positive), residue designation in black].
Molecular events supporting the specific reaction of TXNPx with TXN were
suggested by molecular modeling (see Figure 3.13). Negative charges of E72,
D76 and D79 in TbTXN are in the right position for electrostatic attraction to
the positive charges of R92, K93 and K94 of the peroxidase, while R128 of the
TbTXN forms a salt bridge to E171 of TbTXNPx. If arranged in that way the
C40 can react with the C173 of the TXNPx (Hofmann et al., 2002).
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Data relevant for TXNPx/TXN interaction
Peroxidase Reductant
Relative activity (%)
TbH6TXNPx TbH6TXN (100)
TbH6TXNPx TbTXNC40SH6 0
TbH6TXNPx TbTXNC43SH6 0.2
TbH6TXNPx TbH6TXND76K 48
TbH6TXNPx TbH6TXND79K 111
TbH6TXNPx TbH6TXN76K,D79K 52
TbH6TXNPx TbH6TXNE72R 41
TbH6TXNPx TbH6TXNR128D 9
Table 3.5: Relative activities of TbH6TXN muteins in the TXNPx test as described in
chapter 2.7.2.. Activity of TbH6TXN is set to 100 %.
The validation of these assumption was checked by mutating the TbTXN
residues implicated and, indeed, charge inversion at the TXN residues, with
the exception of the D79K exchange, significantly reduced activity (see Table
3.5).
3.1.5.1 Verification of TXN/TXNPx interaction by MS
A particular challenge was how to get information on the shape of a catalytic
intermediate such as “H“ in Figure 3.9. The proposed catalytic intermediate, in
which TXN is linked to the peroxidase could never be identified, because it is
evidently processed too fast.  A mutated substrate that still can react with the
oxidized peroxidase but is no longer able to complete the catalytic cycle by
thiol/disulfide exchange, could freeze in the state of a catalytic intermediate.
To this end the hidden C43 was mutated to serine, while the solvent-exposed
C40 was left unchanged. The mutein showed practically no activity (see Table
3.5). An intermediate was obtained by co-oxidation of the TbTXNPx with the
mutein TbTXNC43S and separated from excess of TbTXNC43S by gel
permeation. The intermediate was cleaved by trypsin and chymotrypsin and
peptides not bigger than 2500 Da were obtained that were detectable by ESI
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(electronspray ionization mass spectrometry) analysis. A peak of a molecular
mass from 1988.8 Da could be found which matched with the predicted size of
the amino acid residues 36-44 of TbTXNC43S (containing the active C40)
linked by a disulfide bond to the fragment 169-177 of the TbTXNPx (containing
the active C173 imbedded in the C-terminal VCP motif).
Figure 3.14: Mass spectrum of TbTXNC43S/TbTXNPx intermediate cleaved by trypsin
and chymotrypsin. Both proteins were discovered with a sequence coverage of 82.3 %
of TbTXNC43S and that of TbTXNPx with 80 %. The peptides of TbTXNC43S are shown
in red and of TbTXNPx are shown in green. The insert shows the MS/MS analysis of
the C40/C173-linked fragments.
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Figure 3.15: MS/MS sequencing of the disulfid-linked proteolytic fragment revealing
the TXN/TXNPx interaction. The amino acid sequence of both peptide moieties could
be deduced from two complementary series of N-terminal (bn) and C-terminal (yn)
fragment ions depicted in green (HGVCPANW) and red (SASWCPPSR), respectively.
Due to the low intensity of the parent ion, some signals resulting from a contamination
of the instrument are also seen (marked by asteriks)
The peak eluting with the predicted size was analyzed by MS/MS and the
sequences of the peptides 36-SASWCPPCR-44 and 169-HGEVCPANW-177
could be verified.
The results comply with the hypothetical reaction mechanism and with
molecular models of TXN/TXNPx intermediates from T. brucei brucei or C.
fasciculata (Flohé et al., 2002a; Hofmann et al., 2002; Budde et al., 2003a). It
is the first time that this interaction is corroborated. According to our data, the
reductive part starts with an attack of the solvent exposed cysteine (C40) of
the TXN on the distal conserved cysteine (C173´) of the peroxidase.
3.1.5.2 Reaction stoichiometry
From molecular modeling it was known that the decameric TbTXNPx has ten
putative reaction centers. If all ten binding-sites react with the substrate TXN at
the same time remained elusive. Therefore the intermediate-state of
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TbTXNPx/TbTXNC43S was reduced with β-Mercaptoethanol and the
presence of both, TbTXNPx and TbTXNC43S was verified by SDS-gel
electrophoresis. Appropriate calibration of the gel with the single components
revealed that the intermediate contained one molecule of TbTXNC43S per
subunit of TbTXNPx (see Figure 3.16). The stoichiometry was confirmed by
gel permeation of the reductively cleaved TbTXNPx/TbTXNC43S intermediate
(data not shown). The protein concentration of the peak areas were calculated
from E280 and the respective extinction coefficients were calibrated by amino
acid analysis (εTXNC43S 280 = 0.92 mg-1cm-1; εTXNPx 280 = 0.42 mg-1cm-1)
14 kDa
30 kDa
43 kDa
20 kDa
TbTXNPx
TbTXNC43S
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lane number
Figure 3.16: Denaturating SDS-PAGE showing different concentrations of TbTXNPx,
TbTXNC43S and the intermediate. lane 1: molecular weight marker (GibcoBRL,
Karlsruhe, Germany); lane 2: TbTXNPx 32 pmol; lane 3: TbTXNPx 16 pmol; lane 4:
TbTXNPx 8 pmol; lane 5: TbTXNPx 4 pmol; lane 6 and 7: intermediate; lane 8:
TbTXNC43S 6 pmol; lane 9: TbTXNC43S 12 pmol; lane 10: TbTXNC43S 24 pmol; lane
11: TbTXNC43S 48 pmol; After measuring the density of the bands the concentration
of TbTXNC43S in the intermediate was calculated to be 10.3 ± 4.21 pmol and the
concentration of TbTXNPx 10.5 ± 3.8 pmol.
3.1.5.3 Recovery of TXNPx activity from a dead-end intermediate by
trypanothione
When TbTXNPx thus modified with the dead-end substrate TbTXNC43S, was
tested for activity in the conventional assay, it expectedly proved to be
inhibited, but gradually recovered when exposed to T(SH)2 and the authentic
TXN. The recovery is time-dependent and a specific activity up to 89% of the
starting value was re-established within 30 min (see Table 3.6). That
corroborates the assumption that the pseudosubstrate reacted in the
anticipated way and did not damage the structure of the peroxidase.
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time [min] specific activity [%]
control without TbTXNC43S 100
1 51
11 74
21 84
31 89
Table 3.6: Recovery of reactivity of TbTXNPx after a dead-end intermediate was built.
The assay mixture contained, 300 µM NADPH, 1 U/ml TR, 50 µM TbTXNC43S, 10 µM
TbTXNPx and 70 µM t-bOOH, was pre-equilibrated for 15 min at 25 °C before 10 µM
TbTXN was added to the reaction mixture. The whole mixture was incubated for 1, 11,
21, 31 min before the reaction was started by addition of 130 µM T(SH)2.
3.1.5.4 Electron microscopic studies of the dead-end intermediate
A model that reveals that all reaction centers of the decameric peroxidase may
simultaneously react with the reducing substrate was created by Hofmann et
al. (2002). Electron microscopy of the intermediate, which eluted with an
apparent molecular weight beyond 300,000 Da from a gel chromatography
column, showed almost exclusively ring-like structures which appeared larger
and had adopted a pentangular shape. When the material was tested on a
reducing SDS gel, bands corresponding to the sizes of TbTXNPx and
TbTXNC43S were detected.
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Figure 3.17: Elution profile and shape of pseudo-substrate-loaded decamer TbTXNPx.
TbTXNPx co-oxidized with excess of TbTXNC43S was subjected to gel permeation.
The covalent intermediate of TbTXNPx and TbTXNC43S elutes with an apparent MW of
300,000 Da. Excess of TbTXNC43S that is partially dimerized is separated (upper
panel). The pentangular shape of the intermediate as appearing in electron
microscopy, is shown in the middle panel and indicated by black arrows. Identity of
the peaks is shown in the SDS-PAGE below.
The model of the intermediate has predicted almost equidistant attachment of
the ten TXN molecules to the decameric peroxidase (Hofmann et al., 2002),
which appeared incompatible with the pentangular shape of the intermediate
seen by electron microscopy. An idealized shape of the structure was obtained
by averaging about 1,000 individual e. m. pictures. The resulting shape of
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electron density was compared with a re-newed model of TbTXN-loaded
TbTXNPx (see Figure 3.18). The idealized shape of unloaded reduced TXNPx
forms an almost regular ring and fits to the predicted model as is shown in
Figure 3.18.
Figure 3.18: Comparing reduced TbTXNPx in shape and model with intermediate
(TbTXNPx/TbTXNC43S). (A) Panel of e. m. images obtained with DTT reduced
TbTXNPx. (B) Analogous panel of images obtained by co-oxidation of TbTXNPx with
TbTXNC43S. (C) Idealized shape (green net) of reduced TbTXNPx, as obtained by
averaging individual e. m. pictures of (A), fitted to a space filling model of decameric
TbTXNPx. The five dimers are highlighted by different colors. (D) Shape of TbTXNPx
loaded with ten molecules of TbTXNC43S, as derived from images in (B), fitted to the
model of intermediate. The color code of the model is: orange, carbon atoms of
TbTXNPx; black, carbon atoms of TbTXNC43S; blue, nitrogen; red, oxygen; yellow,
sulfur.
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As demonstrated in Figure 3.18, the fit of the models and the e. m.–derived
shapes may be rated as highly satisfactory.
3.2 Results of related cooperative projects
The following chapters describe contributions to collaborative projects related
to hydroperoxide metabolism of Kinetoplastida and other pathogens. Results
are here briefly summarized in the context of the entire projects. The own
contributions to each of the projects are indicated as footnotes at the end of
the chapters.
3.2.1 Structures of CfTXN revealing interaction with trypanothione*
Tryparedoxins are redox-active proteins which have been discovered in
Trypanosomatids as thioredoxin-related proteins (Nogoceke et al., 1997;
Lüdemann et al., 1998; Montemartini et al., 1998a; Guerrero et al., 2000b;
Lopez et al., 2000). TXN accepts its reduction equivalents from the unique
redox mediator trypanothione, N1, N8-(bis)-glutathionylspermidine, and
transfers them to tryparedoxin peroxidase, that can reduce hydroperoxides.
Reduced trypanothione is consumed and regenerated by a NADPH-dependent
flavoprotein, the trypanothione reductase.
Figure 3.19: Structural formula of the bis-(glutathionyl)-spermidine conjugate
trypanothione (Steenkamp, 2002).
A model for TXN/trypanothione interaction was developed based on the known
structures of CfTXN1 and CfTXN2 (Hofmann et al., 2001) and the following
assumptions: (i) TXN displays ping-pong kinetics which implies independent
interactions with both substrates (T(SH)2 and TXNPx). The reduced TXN
reacts with the oxidized TXNPx (Gommel et al., 1997) and oxidized TXN is
reduced by trypanothione. (ii) Since the thiol sulfur Cys41 is the only one
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accessible from the solvent side, it must be considered to be attacked by an
SH group of trypanothione. Therefore a mixed disulfide between TXN and
trypanothione is achieved as a catalytic intermediate. (iii) Binding of the highly
ionized substrate was presumed to be of electrostatic nature as in glutathione
utilizing enzymes (Epp et al., 1983; Karplus and Schulz, 1989; Aumann et al.,
1997). (iv) The differences to glutathione lie in the spermidine moiety and the
carboxylate groups on both ends of trypanothione. Since permutation of the
active site motif of CfTXN2 did not adequately explain substrate specificity
(Steinert et al., 2000), it is assumed to be achieved by residues remote from
the reaction center.
Screening of the surface of CfTXN2 for exposed charged residues suitable to
attract a trypanothione molecule that is bound to the Cys41 via a disulfide
bridge, showed the guanidino group of R129 in an ideal position to bind the
carboxyl group of the N1-bound glutathionyl residue. The spermidine nitrogen
can be brought in the vicinity of the Glu73 carboxylate of TXN. Further
electrostatic forces between the N1-bound glutathione and the residues Ile110-
Pro111 analogous to experimental thioredoxin complexes (Qin et al., 1995;
Doublie et al., 1998), stabilize the TXN/trypanothione complex (see Figure
3.20). The proposed model is consistent with functional characteristics of the
CfTXN2 variants of the residues Glu73 and Arg129, each having the charge
inversed. When freshly prepared, both muteins E73R and R129D shared
similar CD-spectra with the wild-type enzyme and thus confirmed native
conformation under these conditions. The specific activities of the freshly
prepared CfTXN2H6-E73R and R129D muteins were 17 % and 2 % of that of
the wild-type enzyme. The mutein E73R declined its activity to 12 %, when
stored at 4 °C over one day, that goes parallel with a denaturation of the
enzyme as could be confirmed by marked changes in the CD spectrum. The
instability of CfTXN2H6E73R and the marginal activity of the R129D mutein
precluded a detailed kinetic analysis. The low activities of the freshly prepared
muteins support the involvement of the residues Arg129 and Glu73 of the
CfTXN2 in trypanothione binding predicted by the model (see Figure 3.20).
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Figure 3.20: Modeling of trypanothione onto CfTXN2 showing the presumed
intermediate, where the sulfur of the N1-glutathionyl residue of trypanothione has
reacted with the sulfur of Cys41. Residues implicating the trypanothione binding are
shown as balls and sticks and the corresponding CfTXN2 is shown as a ribbon
diagram.
* Own contributions to this chapter: Constructions and preparation of the
muteins CfTXN2E73R; CfTXN2R129D; activity determination; verification of
the amino acid exchange by tryptic cleavage and MALDI.
3.2.2 Tryparedoxin peroxidase of Leishmania donovani **
A novel peroxiredoxin was isolated from L. donovani (Flohé et al., 2002a), the
causative agent of fatal visceral Leishmaniasis. The TXNPx was investigated
kinetically and subjected to molecular model-based mutagenicity for a better
understanding of the catalytic events. Heterologous expression of the
LdTXNPx and variant genes in E. coli BL21(DE3) yielded proteins
corresponding to the predicted size of 23,175 Da as was verified by MALDI-
TOF spectrometry and gel electrophoresis. The native state of the variants
were confirmed by CD spectra (The α-helix content of the wild-type
LdH6TXNPx was near 20 %). The N-terminally His-tagged proteins were
easily purified in one step by nickel chelate chromatography.
LdH6TXNPx proved to be an active peroxidase as it equally accepted
CfTXN1H6 and CfTXN2H6. The specificity of LdH6TXNPx for hydroperoxide
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substrates, like that of other TXNPxs (Nogoceke et al., 1997; Castro et al.,
2002a; Budde et al., 2003a), is broad. It reacts with H2O2, t-bOOH, cumene
hydroperoxide, linoleic acid hydroperoxide, and phosphatidyl choline
hydroperoxide. Surprinsingly, the lipid hydroperoxides were incompletely
reduced, as it was observed for LimTXNPx (Castro et al., 2002a) and
TbTXNPx (Budde et al., 2003a), under standard test conditions due to
substrate-induced inactivation with time (see Figure 3.21).  While the reaction
with t-bOOH always was complete (trace A), the reaction with phosphatidyl
choline hydroperoxide slows down to marginal rates (trace B) (see Figure
3.21). Addition of t-bOOH at that time to the reaction confirmed that the
enzyme activity has declined substantially (compare trace A and trace B). This
suicide reaction was partially overcome by increasing the concentration of
LdH6TXNPx (trace C), but slowed down to marginal rates long before the Gpx-
4-reactive hydroperoxy groups (trace F) have been consumed. The same kind
of inactivation could be seen with linoleic acid hydroperoxide (trace D). When
the enzyme concentration is high enough to allow a completed reaction within
10 s, the enzyme remains active (trace E). The activities of LdH6TXNPx
compared with other TXNPxs are listed in Table 3.2.
Figure 3.21: Original recordings of the LdH6TXNPx reaction demonstrating substrate-
induced inactivation. Activity assays are performed as described in chapter 2.7.4 but
with 2.3 µM (traces A, B, and D) or 4.6 µM (traces C and E) LdH6TXNPx. A difference of
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absorbance ∆E = 0.441 corresponds to total consumption of hydroperoxide (70 µM in
all experiments). The reduction of PCOOH (trace B) and peroxidized linoleic acid
LOOH (trace D) by LdTXNPx is incomplete due to inactivation, as evident from
reduced activity with t-bOOH after pre-exposure to the lipid hydroperoxides. In trace C
and E substrate-induced inactivity is partially overcome by increased enzyme
concentration. Trace F demonstrates the determination of 70 µM PCOOH by means of
GPx-4 reaction in an analogous test system described in chapter 2.7.3.
As observed in previous mutagenesis studies of CfTXNPx (Montemartini et al.,
1999), an exchange of the active site cysteines to serines leads to abrogated
(C52S) or marginal activities (C173S). LdH6TXNPxC52S was also inactive in
the glutamine synthetase protection assay (Kim et al., 1988), but
LdTXNPxC173S showed considerable activity (see Figure 3.22).
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Figure 3.22: Protection of glutamine synthetase by LdTXNPx and its variants against
oxidative denaturation described by Kim et al. (1988). Data are presented as
percentage of residual activity. The “negative control” contains no enzyme at all and
in the “positive control” the catalytic iron ions are complexed by 1 mM EDTA. Samples
were withdrawn in 30 s intervals, which implies that the decline of glutamine
synthetase activity already seen with LdH6TXNPxC173S and LdH6TXNPxC52S at t0
reflects glutamine synthetase activity after 90 and 120 s.
72                                                                                                                                    RESULTS
This assay monitores the oxidative denaturation of glutamine synthetase by
H2O2 generated in an aerobic solution of FeCl3 and dithiothreitol.
Peroxiredoxins delay the process by reducing H2O2 using thiol as an
unspecific reducing substrate (Netto and Stadtman, 1996). These finding
support the view that C52 is the residue that is oxidized by the peroxide
substrate. That conclusion was further supported by molecular models, based
on the structure of CfTXNPx (Alphey et al., 2000), of the reduced LdTXNPx.
The LdTXNPx models, supported by mutagenesis studies, proved to be
extremely helpful in understanding the catalytic principles of the two active site
cysteines (Flohé et al., 2002a).
** Own contribution to this chapter: Detection of substrate-induced inactivation;
Construction and preparation of the LdH6TXNPxC173S mutein; investigations
of LdTXNPx muteins by glutamine synthetase protection assay.
3.2.3 AhpC of Mycobacterium tuberculosis***
A peroxiredoxin, the AhpC of M. tuberculosis, became of interest, as it is
overexpressed in strains that are resistant to isoniazid (Sherman et al., 1996;
Deretic et al., 1997; Manca et al., 1999).
The gene coding for the alkyl hydroperoxide reductase subunit C (AhpC) of
Mycobacterium tuberculosis was amplified from genomic DNA, of the strain
No. 4611 Reconquista from Argentine, that was a clinical isolate. The gene
product was expressed heterologously in E. coli BL21(DE3) containing an N-
terminal His-tag, and could easily be purified by a one step chelate
chromatography. The activity as a peroxiredoxin-type peroxidase could be
verified by glutamine synthetase protection assay as described by Kim et al.
(1988). The protection of the glutamine synthetase against oxidative
denaturation could be achieved by AhpC to 98 % of residual activity, after 30
min incubation. The search for possible reaction partners was done by T.
Jäger.
*** Own contribution to this chapter: Construction of AhpC expression vector
(Diploma thesis); large scale production; verification of activity.
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3.2.4 Specificity and kinetics of a mitochondrial peroxiredoxin of
Leishmania infantum+
In C. fasciculata (Steinert et al., 1999), T. cruzi (Lopez et al., 2000) and T.
brucei (Tetaud et al., 2001) TXN and TXNPx were shown to be localized in the
cytosol by immunohistochemistry. The cytosolic localization of the complete
system appears to be ideal to protect the parasite against oxidative attack from
outside. Kinetoplastida, like higher animals, are also able to produce
endogenous H2O2, as byproduct of the mitochondrial energy metabolism
(Boveris and Stoppani, 1977; Turrens and Cazzulo, 1987; Denicola-Seoane et
al., 1992). This endogenous oxidative stress cannot be balanced by the
cytosolic peroxidase. In L. infatum two peroxiredoxin genes were identified.
One coding for a cytosolic TXNPx (Castro et al., 2002b) and the other, similar
to the mitochondrial peroxiredoxins of T. cruzi (Wilkinson et al., 2000b) and T.
brucei (Tetaud et al., 2001), was indeed shown to localize in this organelle
(Castro et al., 2002b).
The specificity for hydroperoxide substrates of LimTXNPx is similar to those
observed with TbTXNPx (Budde et al., 2003a), LmTXNPx (Levick et al., 1998),
and LdTXNPx (Flohé et al., 2002a). The activity with lipid hydroperoxides is
comparable weak and inactivation by these poor substrates could be objected
(see chapter 3.2.2). The kinetic parameters deduced from LimTXNPx are a
kcat. of 37.0 s-1 and KM values of 31.9 and 9.1 µM for CfTXN2 and t-bOOH,
respectively. Size and shape of the native enzyme was elucidated by light
scattering, gel chromatography, and electron microscopic studies. The majority
of LimTXNPx molecules were recognized as ring-like structures, with an
apparent molecular weight of 270 kDa, as was calculated for the decameric
peroxidase. Therefore LimTXNPx is assumed to preferentially adopt a state of
oligomerization identical to that of CfTXNPx in crystals (Alphey et al., 2000).
The kinetic pattern obtained for LimTXNPx is similar to that observed for
TbTXNPx (Budde et al., 2003a), deviating from the normal ping-pong pattern
as observed for other TXNPxs. The regression lines of the primary Dalziel plot
are converging and the coeffizient Φ1,2, that characterizes a ternary complex,
is not zero (Castro et al., 2002a). As judged by the chemical process and the
knowledge of the structure, such a complex between the enzyme and both
substrates is not assumed to be formed. These findings could possibly be
attributed to a cooperativity of the reaction centers, as is not uncommon in
oligomeric proteins (Koshland, 1970).
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+ Own contribution to this chapter: Instruction of H. Castro in chelate
chromatography and spectroscopic techniques; know how transfer related to
TXNPx kinetics; investigations of the native molecular weight of LimTXNPx.
3.2.5 Kinetic pattern for L. infantum TXNPx and TXN++
For kinetic analysis the cytosolic form of TXNPx, modified with an N-terminal
His-tag, from L. infantum (LiH6TXNPx) was prepared by Helena Castro (IBMC,
Porto, Portugal) and the TXN1 from L. infantum (LiH6TXN1), cloned into the
vector pET28c(+) to obtain an N-terminal His-tag, was provided from Marta
Santos (IBMC, Porto, Portugal). As oxidizing substrate hydrogen peroxide was
chosen, because LiH6TXNPx, in concentrations ≤ 2 µM, was inactivated by t-
bOOH. The assay was essentially performed as described for TbH6TXNPx
and by Nogoceke et al. (1997), using 1.5 µM of LiH6TXNPx and 70 µM H2O2.
As in that case the spontaneous reaction with T(SH)2 can not be neglected,
blanks, without the cosubstrate LiH6TXN1, had to be measured and
subtracted from each single curve for progression analysis.
LiH6TXNPx primary plot 
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Figure 3.23: Steady-state kinetic analysis of LiH6TXNPx. Example of a double
reciprocal primary plot showing dependency of enzyme-normalized initial velocities
on H2O2 concentrations at 6 different concentrations of cosubstrate (LiH6TXN1) that
were kept constant at regeneration.
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The steady-state analysis of LiH6TXNPx yielded data that essentially complied
with the data of other TXNPxs (see chapter 3.1.3). Enzyme-normalized double
reciprocal primary Dalziel plots (i. e. [E0]/v versus 1/[H2O2]) derived from single
curve progression analysis at various fixed cosubstrate concentrations showed
straight lines which deviate a little bit from parallelity.
Similar to the kinetic pattern of TbH6TXNPx, the slopes of the primary plot are
clearly biphasic, being steeper at high peroxide concentrations. Only the flatter
parts of the curves are used for data processing, because of technical
reasons. The secondary plot shows how the reciprocal apparent maximum
velocities ([E0]/Vmax. app.) obtained as the ordinate intercepts of the primary plot
depend on the reciprocal cosubstrate (LiH6TXN1) concentrations. It provides
the limiting maximum velocity (Vmax. = ordinate intercept) and the limiting KM
value for the LiH6TXN1 (abscissa intercept). An attempt to calculate Φ1,2 from
a total of 18 primary slopes did not yield a value that differed significantly from
zero.
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Figure 3.24: Secondary Dalziel plot for LiH6TXNPx demonstrating the reciprocal
apparent maximum velocities for infinite hydrogen peroxide concentrations in relation
to the reciprocal LiH6TXN concentrations.
The catalytic cycle thus represents an enzyme-substitution mechanism, which
in the kinetic analysis is reflected in a ping-pong pattern as observed with
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other peroxiredoxins (Nogoceke et al., 1997; Montemartini et al., 1999;
Guerrero et al., 2000a; Baker et al., 2001; Flohé et al., 2002a).
Φ0 [s] Φ1 [s µM] Φ2 [s µM]
KM HOOH
[µM]
KM LiTXN1
[µM]
Vmax.
[µM s-1]
kcat. [s-1]
0.32 7.99 1.61 25.19 5.08 1.58 3.15
Table 3.7: Kinetic constants for the LiH6TXNPx. Reaction with LiH6TXN1 and hydrogen
peroxide, as analyzed according to Dalziel (1957).
Minor differences in the kinetic pattern that are observed between
peroxiredoxins depend on the relation of rate constants for complex formation
and reactions within complexes. Saturation kinetics may be observed, as
reported here for LiH6TXNPx, TbH6TXNPx and previously for LdTXNPx
(Flohé et al., 2002a) and TcTXNPx (Guerrero et al., 2000a), or not, as
reported for CfTXNPx (Nogoceke et al., 1997) (see Table 3.3).
Like tryparedoxins from C. fasciculata (Gommel et al., 1997; Montemartini et
al., 1998a; Guerrero et al., 2000b) and T. brucei brucei (Lüdemann et al.,
1998), the tryparedoxin, a thioredoxin-related protein from L. infantum
catalyzes the reduction of a peroxiredoxin-type peroxidase, LiH6TXNPx, at the
expense of trypanothione. Kinetic characterization of the enzyme was initially
performed as described by Gommel et al. (1997). The variation of the
LiH6TXNPx concentration from 1.5 to 20 µM resulted in an inhibition of the
peroxidase at concentrations higher than 3 µM. Therefore the assay mixture
contained 300 µM NADPH, 1 U/ml trypanothione reductase, 0.56 µM
LiH6TXN1, LiH6TXNPx in a range from 1.5 to 2.5 µM and trypanothione in
concentrations from 10 to 300 µM. The reaction was started after 15 min of
incubation with 70 µM H2O2. The kinetic analysis revealed a kinetic pattern
which, as in the case of CfTXNs, complies with the ping-pong mechanism and
can be described by the simplified Dalziel equation:
Φ1 Φ2[E0]
v Φ0 [A] [B] ++=
Equation 3.2: Simplified Dalziel equation for a typical ping-pong or enzyme-
substitution mechanism, wherein the term Φ1,2/[A] [B] is zero. [A] is the molarity of
peroxiredoxin and [B] that of trypanothione.
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Figure 3.25: Enzyme-normalized double reciprocal primary plots ([E0]/v versus
1/[LiH6TXNPx]) derived from measurements at various fixed co-substrate [T(SH)2]
concentrations.
The primary Dalziel plot of LiH6TXN1 shows straight lines that do not deviate
significantly from parallelity, which complies with the proposed ping-pong
mechanism as reported for other TXNs (Gommel et al., 1997; Montemartini et
al., 1998a; Guerrero et al., 1999).
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Figure 3.26: The secondary plot of LiH6TXN1. The apparent maximum velocities
([E0]/vmax.app.) were plotted versus the reciprocal cosubstrate concentrations
(1/[T(SH)2])
As demonstrated in Figure 3.26, a double reciprocal plot of the apparent Vmax.
for infinite [LiH6TXNPx] against cosubstrate concentration shows three lines
intersecting the ordinate at zero, within experimental errors. Ping-pong kinetics
with infinite KM and infinite Vmax. are thus observed, which are not unusual for
oxidoreductases as previously reported for glutathione peroxidases (Flohé et
al., 1972; Ursini et al., 1995) and CfTXNPx (Nogoceke et al., 1997).
Φ0 [s] Φ1 [s µM] Φ2 [s µM]
KM LiTXNPx
[µM]
KM T(SH)2
[µM]
Vmax.
[µM s-1]
kcat. [s-1]
∼ 0 1.56 ± 0.61 24.91 ± 0.22 ∞ ∞ ∞ ∞
Table 3.8: Kinetic coefficients of LiTXN1. Reaction was performed with LiH6TXNPx,
T(SH)2 and analyzed according to Dalziel (1957).
The kinetic pattern, however, does not exclude the formation of specific
enzyme-substrate complexes, but it predicts that the decay of any such
complexes cannot be the rate-limiting step of the overall reaction. The
constants k´1 and k´2 determine the apparent limiting rates for the net oxidation
and reductive regeneration of LiTXN1 and are defined as the reciprocal values
of the empirical Dalziel coefficients Φ1 and Φ2.
++ Own contributions to this chapter: Complete kinetic analysis of LiH6TXNPx
and LiH6TXN1.
3.2.6 Inhibitory activity of N1, N8-bis-(γ-Glu-Ala-Gly)-spermidine towards
tryparedoxins+++
A pseudosubstrate of TXN was synthesized in which the redox active
glutathione residues were replaced by ophthalmic acid (γ-glutamyl-alanyl-
glycine). The use of the pseudosubstrate was expected to better disclose the
molecular interactions than trypanothione itself, which, upon reaction,
becomes a cyclic disulfide that does no longer interact with the enzyme.
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Figure 3.27: Structure of the Bis-(ophthamyl)-spermidine, a homologue of T(SH)2 in
which the both cysteines are replaced by alanines.
The redox inactive homologue of trypanothione weakly inhibited the two TXN
isozymes of C. fasciculata and TXN of T. brucei. A slightly inhibition could be
detected by adding 500 fold excess of pseudosubstrate over trypanothione to
the reaction (see Figure 3.28).
controle with
2 µM T(SH)2
with 2 µM
T(SH)2 and
1000 µM
inhibitor
Figure 3.28: Inhibition of CfTXN1 by bis-(ophthamyl)-spermidine. The weak inhibitor, in
which the two cysteines were replaced by alanines, occupied the T(SH)2 binding sites.
Inhibition constants, calculated on the basis of a competitive inhibition with
trypanothione, were in the high micromolar range, as was to be expected from
weak TXN/trypanothione interaction. The interactions primarily seem to
depend on electrostatic attractions of the substrate´s carboxyl functions and
arginine residues at the enzyme surface (Hofmann et al., 2001) (see chapter
3.2.1).
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T(SH)2
[µM] 0.72 0.96 1.32 2.64
pseudosubstrate
[µM] Inhibition [%] Ki [µM]
CfTXN1
400
800
1500
33.8
54.3
76.0
27.4
45.7
71.4
25.0
47.1
67.5
16.2
35.0
59.6
524.9 ± 106.9
CfTXN2
400
800
1500
26.1
47.0
71.4
26.6
46.2
72.0
25.6
44.5
68.1
21.4
40.2
65.1
791.1 ± 192.0
TbTXN
400
800
-
-
30.6
50.8
-
-
-
-
603.0 ± 97.0
Table 3.9: Inhibitory activity of the bis-(ophthamyl)-spermidine. The type of inhibition
was characterized as competitive with the tryparedoxins of Chrithidia fasciculata
(CfTXN) the isoenzymes 1 and 2 and the tryparedoxin of T. brucei (TbTXN). The weak
inhibition is charaterized by the high Ki values.
+++ Own contributions to this chapter: Determination of inhibition constants.
3.2.7 RNA interference constructs of TbTXNPx and TbTXN#
The discovery of double-stranded RNA interference (dsRNAi) in Trypanosoma
brucei provided a convenient method to generate knockout phenotypes in this
protozoan parasite (Ngo et al., 1998). The presence of double-stranded RNA
(dsRNA) in the cell dominantly silences gene expression in a sequence
specific manner by causing the corresponding endogenous RNA to be
degraded (Bosher and Labouesse, 2000). The technique of dsRNA
interference was first described in the nematode Caenorhabtidis elegans (Fire
et al., 1998) and later observered in Drosophila (Kennerdell and Carthew,
1998; Misquitta and Paterson, 1999), hydra (Lohmann et al., 1999), planaria
(Sanchez Alvarado and Newmark, 1999), zebrafish (Wargelius et al., 1999; Li
et al., 2000), mice (Wianny and Zernicka-Goetz, 2000), and trypanosomes
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(Ngo et al., 1998). As the double-stranded RNA interfere with the gene
expression at the RNA level, it significantly reduces time and effort to generate
knockout phenotypes.
A trypanosomal RNA interference plasmid, p2T7, was kindely provided from
Dr. John E. Donelson (Dep. of Biochemistry, University of Iowa, IA, USA). The
plasmid containes two tetracycline inducible T7 promoters in the opposite
orientation. This promoter arrangement generates transcripts of both strands
of DNA inserted between the promoters, which spontaneously form dsRNA in
the cells. As a counterpart the plasmid needs a specialized host cell line called
T. brucei 13-90 in which the genes for the bacteriophage T7 RNA polymerase
(T7RNP) and the bacterial tetracycline repressor protein (TetR) have been
inserted into the genome via the plasmids pLew13 and pLew90 (Wirtz et al.,
1999). In this cell line the T7 RNA polymerase and the tetracycline repressor
are expressed constitutively in a level that does not harm the cells and provide
a thight regulation of the tetracycline operator. A third plasmid containing a
sequence under the control of a tetracycline inducible T7 promoter can be
transfected and modulated by the addition of tetracycline to the medium. The
genes of TbTXN and TbTXNPx were cloned into the p2T7 vector by the
HindIII/BamHI-BglII restriction sites and confirmed by PCR and DNA
sequencing.
T. brucei
Actin 3´ UTR
T7
tet
T. brucei
 rRNA promoter
TbTXN
term
term
tet
T7
BLEO
NotI HindIII BamHI
T. brucei 
5´and 3´ ACT
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TbTXNPx
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B
Figure 3.29: Schematic diagram of the plasmid p2T7 containing TbTXN (A) or TbTXNPx
(B). Abbreviations are, T7, promoter for T7 polymerase; term, two adjacent termination
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signals for the T7 RNA polymerase; tet, tetracycline operator; BLEO, phleomycin
resistant gene; Actin 3´ UTR, Actin 3´ untranslated region.
As TbTXN is a catalysator for the ribonucleotide reductase, a knockout of that
gene would expect arrested cells that cannot proliferate anymore. The
construct of p2T7 containing the whole gene sequence of TbTXN were
transfected to T. brucei 13-90. As a control of the ribonucleotide reductase
function of TbTXN, incorporation of 3H-labled Thymidine to the DNA during
proliferation was measured. Preliminary tests showed that the cell growth of
the tetracycline induced cells is inhibited (not shown) and nearly no
incorporation of 3H-thymidine occured over 48 hours.
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Figure 3.30: The incorporation of 3H-marked thymidine to bloodstream trypanosomal
strain 13-90, transfected with p2T7 containing TbTXN was calculated in percentage.
The cells induced with 1 µg/ml tetracycline were compared with uninduced cells at 0,
8, 24, 32, and 48 hours after induction.
Western blot analysis confirmed that the observed phenotype is correlating to
RNA interference of TbTXN. Cell extracts correlating to 0, 8, 24, 32, and 48
hours after induction with 1 µg/ml tetracycline were separated on a 15 % SDS-
PAGE and incubated with anti-CfTXNPx and anti-CfTXN1 rabbit serum. The
protein bands of TbTXNPx could be seen over 48 hours and abrogated after
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72 hours. After 8 hours of induction no tryparedoxin of T. brucei could be
detected by Western blot (see Figure 3.31).
   1        2        3       4        5         6        7       8
lane number
15 kDa
25 kDa
35 kDa
55 kDa
70 kDa
TbTXN
TbTXNPx
Figure 3.31: Western blot analysis of T. brucei 13-90 transfected with p2T7 containing
TbTXN after induction with 1 µg/µl tetracycline. CfTXNPx and CfTXN1 antisera were
used. lane 1 and 8: Prestained protein marker (MBI, Fermentas, St. Leon-Roth,
Germany); lane 2: cell extract directly after induction with tetracycline; lane 3: 8 hours
after induction; lane 4: 24 hours after induction; lane 5: 32 hours after induction; lane
6: 48 hours after induction; lane 7: 72 hours after induction.
These preliminary results have to be confirmed with further experiments and
will be done by M. Comini.
# Own contributions to this chapter: Construction of vectors; preliminary
experiments as described.
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4 Discussion
4.1 Reconstitution of kinetoplast peroxidase systems
Reduction of hydroperoxides, as an essential part of the biological antioxidant
defense is, by definition, catalyzed by peroxidases. In Kinetoplastida the low-
efficiency peroxiredoxin-type peroxidases, tryparedoxin peroxidases, seem to
be the major, if not the only, peroxide detoxifying enzymes, since they lack the
more efficient mammalian peroxidases such as catalase and the selenium-
containing glutathione peroxidases (Flohé et al., 1999; Krauth-Siegel et al.,
2003). The first trypanosomatide peroxidase was purified from Crithidia
fasciculata and shown to be active in a cascade composed of NADPH,
trypanothione reductase, trypanothione, and tryparedoxin (Nogoceke et al.,
1997). In comparison to the classical glutathione peroxidases, the activities of
tryparedoxin peroxidases are usually 2 – 3 orders of magnitude lower. This
might be compensated by the extremely high cellular concentration, being 6 %
of the total soluble protein of C. fasciculata (Nogoceke et al., 1997). TXNPx is
oxidized by hydroperoxides and reduced at the expense of tryparedoxin. TXNs
are thioredoxin-related enzymes that are specifically reduced by trypanothione
(Gommel et al., 1997; Nogoceke et al., 1997). They differ in their molecular
weight of 16 kDa and in the active site motif CPPC from classical thioredoxins
with CGPC, and glutaredoxins with CPYC. Trypanothione, a bis-(glutathionyl)
derivative of spermidine (Fairlamb et al., 1985), is synthesized from GSH,
spermidine, and ATP  (Henderson et al., 1990; Koenig et al., 1997; Oza et al.,
2002; Comini et al., 2003) and regenerated of its oxidized cyclic disulfide by
the flavoprotein, trypanothione reductase (Fairlamb and Cerami, 1992; Krauth-
Siegel et al., 2003). The NADPH supplying trypanothione reductase is
homologous to glutathione reductase, lipoamide reductase, thioredoxin
reductase and the bacterial AhpF (Williams, 1992; Flohé, 1998). Despite the
use of phylogenetically related components, the hydroperoxide detoxification
system of Kinetoplastida is the most complex cascade, comprising of three
enzymes and one low molecular weight mediator.
The trypanothione-dependent peroxidase system that was reconstituted from
heterologously expressed proteins, was here described in T. brucei brucei, the
causative agent of Nagana disease. The results may be considered to be also
representative for the homologous systems of T. brucei rhodesiense and T.
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brucei gambiense, the causative agents of African Sleeping sickness in
humans. The TXNPx sequence of T. brucei brucei elucidated here proved to
be identical, for the primer independent amino acid residues, with that of T.
brucei rhodesiense (el-Sayed et al., 1995) and should be very similar to the
second subspecies. A TXN has not yet been isolated from any of the African
trypanosomatids pathogenic in humans, but the TXNs of different species are
highly conserved and can substitute each other in TXNPx assays (Flohé et al.,
2002b). The trypanothione system may also play an important role in the
virulence of the human pathogens, as it has been demonstrated for the TR
synthesis in T. brucei brucei (Krieger et al., 2000). Bloodstream cells were
generated with only one TR gene under the control of a tetracycline inducible
promoter. The TR synthesis could be shut down to 10 % of wild-type activity
and the parasites became substantially more sensitive to H2O2 and resulted in
an arrest of proliferation (Krieger et al., 2000). Therefore TbTXN and TbTXNPx
are valuable tools in the search for trypanocidal drugs.
A trypanothione-dependent hydroperoxide detoxification system was
elucidated in L. infantum (by H. Castro and M. Santos, IBMC, Porto, Portugal),
a human pathogen prevailing in the mediterranean countries. A cytosolic
TXNPx gene was identified that is identical to a peroxiredoxin-type peroxidase
of L. chagasi (Barr and Gedamu, 2001) and almost indistinguishable from
those of other Leishmania species (Levick et al., 1998; Flohé et al., 2002a).
Characterized by two active site VCP motifs, the peroxiredoxin-type
peroxidase is homologous to the TXNPxs of other species of the order
Kinetoplastida (Levick et al., 1998; Tetaud et al., 1998; Lopez et al., 2000;
Castro et al., 2002b; Flohé et al., 2002a). A gene coding for an active TXN
with the characteristic WCPPCR motif was identified in L. infantum, and is  yet
the first tryparedoxin described in the species Leishmania. The cytosolic
localization of the hydroperoxide detoxification system appears ideal to protect
the parasites against oxidative attacks, as expected from the phagocytic attack
of the host.
Since the trypanothione-dependent peroxidase system as detected in C.
fasciculata (Nogoceke et al., 1997) is cytosolic, the search for a
complementing mitochondrial system, comprising the endogenously produced
mitochondrial H2O2, appears rewarding. A second gene coding for a
tryparedoxin peroxidase was isolated from L. infantum (Castro et al., 2002a)
that reminds of the mitochondrial peroxiredoxins of T. cruzi (Wilkinson et al.,
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2000b) and T. brucei (Tetaud et al., 2001). Immunohistochemistry showed that
this protein was indeed localized in this organelle (Castro et al., 2002b). The
mitochondrial form of LiTXNPx (LimTXNPx) differs from the typical cytosolic
tryparedoxin peroxidases in possessing an N-terminal mitochondrial leader
sequence and in the second active site motif, which is IPC instead of VCP.
Despite these differences the LimTXNPx (Castro et al., 2002a) and the
TbmTXNPx (Tetaud et al., 2001) were shown to be tryparedoxin peroxidases.
Overexpression studies of the cytosolic form of LiTXNPx in L. infantum
promastigots showed a marked resistance to exogenous H2O2.
Overexpression of the mitochondrial TXNPx of L. infantum is less effective to
the exogenous H2O2 that likely does not reach the mitochondrion (Castro et
al., 2002b). Therefore the two peroxidases seem to complement each other in
the detoxification of host-derived exogenous hydroperoxides and
endogenously produced mitochondrial H2O2. No mitochondrial tryparedoxin
could yet be identified and the mechanism of how the tryparedoxin peroxidase
is reduced in the mitochondrion remains elusive.
4.2 The growing complexity of kinetoplast peroxide metabolism
The ability to detoxify low hydrogen peroxide concentrations was first
attributed to the spontaneous reduction by trypanothione (Penketh et al., 1987;
Carnieri et al., 1993). Trypanothione is the main redox mediator in
trypanosomatids that can be regenerated from its energetically preferred cyclic
disulfide form (TS2) to reduced T(SH)2 by NADPH and trypanothione
reductase. The expected “trypanothione peroxidase” could never be identified
instead, the reaction turned out to be catalyzed by two distinct enzymes the
tryparedoxin peroxidase and the tryparedoxin (Nogoceke et al., 1997). This
unique pathway of peroxide detoxification was first discovered in the insect
pathogen C. fasciculata (Nogoceke et al., 1997), but seems common to all
pathogenic species of the order Kinetoplastida. TXNPx homologous enzymes
have been characterized in L. major (Levick et al., 1998), T. cruzi (Lopez et al.,
2000), T. brucei (Tetaud et al., 2001), L. infantum (Castro et al., 2002a), and L.
donovani (Flohé et al., 2002a). Tryparedoxins, so far, have been detected in
C. fasciculata (Nogoceke et al., 1997), T. brucei (Lüdemann et al., 1998), T.
cruzi (Lopez et al., 2000; Wilkinson et al., 2000b), and L. infantum (Castro et
al. unpublished).
Over the past three years, the seemingly established trypanosomal
hydroperoxide metabolism has been enriched by further complexities:
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(i) A cytosolic localization of TXN and TXNPx of C. fasciculata has been
reported (Steinert et al., 1999) to compensate the exogenous oxidative attack
of the host. The trypanothione reductase is also considered to be a primarily
cytosolic protein (Smith et al., 1991), although in T. cruzi also association with
the mitochodrion and the kinetoplast was reported (Meziane-Cherif et al.,
1994). A complementary antioxidant defense system in the kinetoplastidal
mitochondria comprising the endogenously produced H2O2 was expected. The
discovery of mitochondrial isoenzymes of TXNPx in T. cruzi (Wilkinson et al.,
2000b), T. brucei (Tetaud et al., 2001) and L. infantum (Castro et al., 2002a)
support the suggestion of an independent mitochondrial peroxide detoxification
system in Kinetoplastida.
(ii) Two peroxiredoxins from L. chagasi, detoxifying hydrogen peroxide,
hydroperoxides, and hydroxyl radicals, were isolated (Barr and Gedamu, 2001;
Barr and Gedamu, 2003). Pxn1 from L. chagasi (LcPxn1) was even able to
detoxify RNIs in addition to ROIs. Like the tryparedoxin peroxidases, the two
peroxiredoxins seemed to be localized to the cytoplasm as it was confirmed by
overexpression of the GFP/Pxn-fusion proteins in L. chagasi (Barr and
Gedamu, 2001).
(iii) A second class of peroxidases, related to glutathione peroxidases, but
containing cysteines instead of selenocysteines, were first studied in T. cruzi
(Wilkinson et al., 2000a). Two isoforms TcGPxI, located to the cytoplasm and
the glycosomes, and the TcGPxII, restricted to the endoplasmic reticulum,
could be characterized (Wilkinson et al., 2002). With glutathione the
peroxidases have marginal activity reducing linoleic acid hydroperoxide and
phosphatidylcholine hydroperoxide but no hydrogen peroxide (Wilkinson et al.,
2000a). Recently TcGPxI was shown to be reduced by a T. cruzi tryparedoxin
resulting in an 8 – 15 fold increase of activity. Three different homologues of
the GPxI gene were found in T. brucei, which are almost identical and differ
only in their N- and C-terminal regions (Hillebrand et al., 2003). Two
peroxidases contain a C-terminal tripeptide ARI and occur in glycosomes and
in the cytosol. The T. brucei GPxIII differs in possessing a C-terminal ARL
motif. The activity of TbGPxIII was studied with hydrogen peroxide, t-bOOH
and cumene hydroperoxide, which are all substrates for the peroxidase.
Regeneration of the reduced GPxIII by the trypanothione/tryparedoxin couple
showed the highest reaction rates compared with that of glutathione (KM
values of about 30 mM) and thioredoxin (Hillebrand et al., 2003).
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(iv) A thioredoxin occurs in T. brucei (Reckenfelderbäumer et al., 2000). It is
reduced by human thioredoxin peroxidase. But no thioredoxin peroxidase in
any organism of the order Kinetoplastida could be detected until now. Beside
the lack of any functional thioredoxin reductase in the parasites, gene
silencing, as it was performed by classical disruption of the gene sequence
and by dsRNA interference showed that Trx is not essential (Schmidt et al.,
2002). The thioredoxin system has been shown to be of vital importance in
mammals (Matsui et al., 1996), as thioredoxins of mammals are involved in a
variety of cellular processes: i. e. they deliver reducing equivalents for
ribonucleotide reductase (RiboR) during DNA synthesis (Holmgren, 1985;
Powis and Montfort, 2001). In trypanosomes this part seems to be undertaken
by tryparedoxin and not by the conventional thioredoxin (Dormeyer et al.,
2001; Krauth-Siegel and Schmidt, 2002).
(v)  A 3-mercaptopyruvate sulfurtransferase (MST) has been reported for L.
major that is able to oxidize thioredoxin and to react with peroxides. Since 3-
mercaptopyruvate is not a natural substrate, the physiological function of the
sulfurtransferase remains uncertain (see Figure 4.1).
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Figure 4.1: A broad spectrum of peroxidases are in charge of antioxidant defense in
Kinetoplastida. Homologous proteins are shown in identically marked circles. TryR,
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trypanothione reductase; TrxR, thioredoxin reductase; T(SH)2, trypanothione; GSH,
glutathione; TXN, tryparedoxin; Trx, thioredoxin; RiboR, ribonucleotide reductase;
MST, 3-mercaptopyruvate sulfurtransferase; Pxn1 + Pxn2, peroxiredoxins; TXNPx,
tryparedoxin peroxidase; GpxI – III, non-selenuim glutathione peroxidases.
Taken together the parasite seems to possess a variety of proteins that react
with peroxides and further studies on their precise role have to be done. But
since knockout studies on thioredoxin proved that this enzyme is not essential
for the parasites (Schmidt et al., 2002) and the glutathione-peroxidase related
enzymes showed only very weak reaction rates with glutathione (Wilkinson et
al., 2000a; Wilkinson et al., 2002; Hillebrand et al., 2003) the detoxification of
hydroperoxides has likely to be attributed to the trypanothione-dependent
tryparedoxin pathway.
4.3 The catalytic cycle of TXNPx
4.3.1 The accepted view
Peroxiredoxins are proteins without any prosthetic group. The only redox-
active residues are cysteines. The typical 2-Cys-peroxiredoxins are identified
by the conservation of two redox-active cysteines as was demonstrated for
tryparedoxin peroxidases. The oxidized proximal cysteine first reacts with the
distal one. As it has become evident from structural data (Hirotsu et al., 1999),
the co-reacting distal cysteine stems from a second inverted subunit of the
oligomeric enzyme (Equ. 1). The reaction center is build up between two
subunits of the homooligomeric protein (Equ. 2). The intermolecular disulfide
bridge is solved by the attack of a reducing dithiol, like tryparedoxin, and
regeneration of the reduced ground state enzyme is achieved.
Equation 4.1: Oxidation of the conserved N-terminal cysteine residue (C52 in TXNPx)
to a sulfenic acid derivative by hydrogen peroxide or an alkyl hydroperoxide (Equ. 1).
This oxidative step is followed by the reaction of the sulfenic acid with the second
conserved cysteine (C173) residue of a secondly inverted oriented subunit (C173´).
The catalytic cycle, as shown, is supported by experimental evidence. The
predicted intermolecular disulfide bridge of the peroxidase, was clearly
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detected in the structure of oxidized human thioredoxin peroxidase (TrxPx)
(Hirotsu et al., 1999). Covalently linked dimers of peroxiredoxins could also be
detected by non-reducing SDS-PAGE (Chae et al., 1994c; Ellis and Poole,
1997b). An exchange of the distal cysteine against a serine resulted in
decreased specific activities when tested with the specific substrates, as
shown for TrxPx of yeast (Chae et al., 1993), for TXNPx of Crithidia fasciculata
(Montemartini et al., 1999), Leishmania donovani (Flohé et al., 2002a) and
Trypanosoma brucei (Budde et al., 2003a), and for AhpC of Salmonella
typhimurium (Ellis and Poole, 1997b). Interestingly, activity in the glutamine
synthetase protection assay is retained in these mutants (Chae et al., 1993;
Flohé et al., 2002a), because they are able to reduce H2O2 by the remaining
solvent-exposed C52 using the thiol, DTT, as an unspecific reducing substrate
(Netto and Stadtman, 1996).
4.3.2 The catalytic triad
Compared to the reaction rates of heme- or selenoprotein-catalyzed reduction
(Flohé et al., 1972; Günzler et al., 1972; Flohé et al., 1999; Krauth-Siegel et
al., 2003), the trypanosomatid system appears slow, but surprisingly fast in
comparison with the glutathione peroxidase homologues whose active site
selenocysteine has been replaced by a cysteine (Rocher et al., 1992; Maiorino
et al., 1995). Those rate constants can only be achieved if the reacting thiol
group is deprotonated by activation (Flohé et al., 2002a; Flohé et al., 2002b).
Mutagenesis studies on L. donovani, based on the crystal structure of TXNPx
of C. fasciculata (Alphey et al., 2000), were performed to get a better insight of
the catalytic mechanism (Flohé et al., 2002a). Replacement of the C52 by
serine abrogated the activity of LdTXNPx completely and the mutein was also
inactive in the glutamine synthetase protection assay (see chapter 3.2.2).
These findings support the view that the C52 is the residue that is oxidized by
the peroxide substrate. This conclusion is further confirmed by molecular
models, as in the reduced state of LdTXNPx the sulfur of C52 is the only
solvent-exposed one. The residue Arg128 seems to be relevant for the
activation of C52, as an exchange to an acidic residue in CfTXNPx
(Montemartini et al., 1999) and LdTXNPx (Flohé et al., 2002a) led to a product
with no measurable activity, without a hint of denaturation. A further candidate
for interaction with C52 could be provided from the model of the reduced
TXNPx. The T49 is in the ideal position for building a hydrogen bond to the
sulfur. Therefore the threonine was replaced by a serine, as a control, and by
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a valine, to get an inert variant. Surprisingly the LdTXNPxT49S showed a
higher activity than the wild-type, and the LdTXNPxT49V variant showed the
expected marginal activity (Flohé et al., 2002a). This results provide a novel
catalytic triad, in which the thiol function of a cysteine is fixed and polarized by
hydrogen bonding with the hydroxyl group of a threonine and forced into
dissociation by the positively charged guanidine group of an arginine. Due to
the conservation of the activating residues the activation mechanism of C52
can be proposed for many other peroxiredoxins.
Molecular modeling and mutation studies proved that the C52 is the only
solvent exposed sulfur in the reduced form of TXNPx and can be attacked by
the peroxide. Inversely the C173´ becomes exposed to the surface upon
oxidation and is the only one to be attacked by the high molecular weight
reducing substrate, TXN. Marginal activity of the TXNPxC173S muteins, and
abolished activity of the TXNPxC52S muteins of C. fasciculata (Montemartini
et al., 1999), T. brucei (Budde et al., 2003a) and L. donovani (Flohé et al.,
2002a), support this suggestions. The insight into the activation mechanism
improves the understanding how a plain protein can become a reasonably
efficient peroxidase, but remain disappointing for the interpretation of
hydroperoxide specificity and sensitivity as it could be observed for TXNPxs of
L. donovani (Flohé et al., 2002a), L. infantum (Castro et al., 2002a), L. major
(Levick et al., 1998), and T. brucei (Budde et al., 2003a). They accept naturally
occuring lipid hydroperoxides with much lower rates and fast inactivation by
these substrates can be observed, in contrast to the TXNPx of C. fasciculata
(Nogoceke et al., 1997), which accepts all oxidizing substrates with
comparable rates. The solved crystal structures of peroxiredoxins (Hirotsu et
al., 1999; Alphey et al., 2000; Schröder et al., 2000; Wood et al., 2002) and
models thereof cannot explain the substrate specificities of TXNPxs, but the
mechanism of inactivation is correlated to an overoxidation of the peroxidatic
cysteine to sulfinic acid (-SO2H) (Wood et al., 2003a; Wood et al., 2003b).
4.3.3 Contributions to TXN/TXNPx interactions
The peroxiredoxin of T. brucei proved to be a tryparedoxin peroxidase, as is
underscored by its specificity for the homologous TbTXN. Some activity could
also be observed with thioredoxin as a reductant, but trypanothione or
glutathione did not yield any measurable activity. As postulated by modeling,
the thiol group of C40 in reduced TbTXN is activated by a network of hydrogen
bridges (Hofmann et al., 2001). Thereby this solvent-exposed cysteine residue
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is dissociated and can react with the C173´ of the oxidized TXNPx to form a
covalent intermediate. In the next step a thiol disulfide exchange within the
catalytic intermediate is generated. The essential reducing thiol is that of C43
of TXN which is shielded from the solvent but can attack C40 to form an
intramolecular disulfide bridge (see Equation 4.2).
Equation 4.2: The sulfhydryl group of C40 in TbTXN is shown to be dissociated to
emphasize its presumed nucleophilic attack on the disulfide bridge of oxidized TXNPx.
The intermediate state (TXN/TXNPx) is dissolved by building an internal disulfide bond
between C40 and C43 of TbTXN.
Exchange of the proximal cysteine C40 to serine abolished the activity
completely, while a marginal activity could be detected if the same exchange
has taken place at C43. The model of the catalytic intermediate between
oxidized TXNPx and the reducing substrate TXN (see Equ. 3; see Figure 3.13)
demonstrates sterically unhindered interaction. The reaction mechanism is
supported by multiple electrostatic attractions between strictly conserved
residues and, thus, common for all tryparedoxin peroxidases in Kinetoplastida
(Levick et al., 1998; Lopez et al., 2000; Tetaud et al., 2001; Castro et al.,
2002a; Flohé et al., 2002a).
A model of the TbTXNPx/TbTXN interaction showed an acidic box on the
surface of TbTXN, comprising of E72, D76 and D79 residues, that could find
its counterparts in the positive charges of R92, K93 and K94 of the peroxidase
(see Figure 3.13). Additionally the R128 of TbTXN is in the right position to
form a salt bridge to E171 of TbTXNPx. The validity of this assumption was
checked by charge-inverting residues of TbTXN. Reduced activity was
observed with all muteins with the exception of TbTXND79K. As the residues
E72 and R128 have been shown to be also relevant to the TXN/trypanothione
interaction in C. fasciculata (Hofmann et al., 2001), mutations thereof would
anyway impair the trypanothione-dependent hydroperoxide detoxification
system.
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NMR studies of the interaction of tryparedoxin with a redox-inactive
homologue of trypanothione further confirmed the suggestions modeled,
based on the crystal structures of CfTXN (Hofmann et al., 2001). The bis-
(ophthamyl)-spermidine is a homologue of T(SH)2 in which both cysteines are
replaced by alanines. Activity assays showed weak inhibition by occupying
T(SH)2 binding sites. When the inhibitor is incubated with CfTXN1 in the
absence of T(SH)2, characteristic shifts are seen in 2D-1H,15N-NMR spectra
(NH resonance) pointing to residues involved in binding. Residues, implicated
in T(SH)2 binding as R128, Cys40, Ile109, Glu72 and Arg44, are evidently
involved in inhibitor interaction (Krumme et al., 2003). Replacing trypanothione
by its redox-inactive homologue underscores the model of TXN/trypanothione
interaction, as developed, based on crystallographic data.
The reaction mechanism of TXNPx with TXN was elucidated by molecular
modeling, based on crystallographic studies (Alphey et al., 2000; Hofmann et
al., 2001; Alphey et al., 2003), supported by mutagenesis studies, as
discussed above, but could never be supported by experimental data on the
proposed catalytic intermediate between TXN and TXNPx, since it is
processed too fast. Using a TXN mutein, in which the C43 was replaced by a
serine, a dead-end intermediate could be achieved, as the second sulfur, for
resolving the complex by building an intrasubunit disulfide bond in TXN, was
missing. Cleavage of this material with trypsin and chymotrypsin followed by
ESI-MS confirmed the presence of a peptide corresponding to the fragments
of TbTXN 36-44 linked to TbTXNPx 169-177. ESI-MS/MS analysis of that
peptide revealed that the fragment indeed correspond to the suggested
disulfide bond between the C40 of TXN and the C173 of the peroxidase
(Budde et al., 2003b). According to the data, the reductive part of the catalytic
cycle of TbTXNPx indeed starts with an attack of the solvent-exposed C40 of
TbTXN on the distal conserved C173´ cysteine of the peroxidase. In
conclusion, the hypothetical mechanism of TXN/TXNPx interaction was for the
first time corroborated by direct physico-chemical analysis of a dead-end
intermediate mimicking the postulated catalytic one. The understanding of the
catalytic mechanism is demonstrating the TXN/TXNPx interaction, but cannot
explain the specificity of tryparedoxin for tryparedoxin peroxidase. The specific
affinity might be strengthened by the C-terminus of TXNPx, whose structure
remains to be established. The tail is obviously swamping during catalysis and
cannot be deduced from the structure of reduced CfTXNPx (Alphey et al.,
2000) or the structure of another peroxiredoxin, HBP23 (Hirotsu et al., 1999).
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4.4 Kinetics and shapes
The kinetic analysis for TbTXNPx, LiTXNPx and LimTXNPx did not comply
with a simple ping-pong mechanism, as is common for peroxidases, where the
oxidation of the enzyme by the hydroperoxide substrate is followed by an
independent reaction with the reductant (Dalziel, 1957; Ursini et al., 1995;
Flohé and Brigelius-Flohé, 2001; Hofmann et al., 2002). Instead the kinetic
pattern speaks in favor of a central complex mechanism, where both oxidant
and reductant should be bound to the active site of the enzyme, before the
reaction can proceed. This kinetic behavior appears incompatible with the
reaction mechanism generally accepted for 2-Cys-Prx as reported for other
peroxiredoxins (Nogoceke et al., 1997; Hofmann et al., 2002; Wood et al.,
2003b). The oxidation of these enzymes by the hydroperoxide is easily
achieved without the aid of the cosubstrate and the reduction by the thiol
cosubstrate does not depend on the presence of a hydroperoxide. Such
reactions of independent enzymatic steps meets the definition of enzyme-
substitution mechanism that should result in ping-pong kinetics, as it has been
reported for peroxiredoxins (Nogoceke et al., 1997; Montemartini et al., 1999;
Guerrero et al., 2000a; Baker et al., 2001; Wood et al., 2003b). The kinetic
pattern of TbTXNPx and LimTXNPx showed non-linear slopes in the double-
reciprocal primary Dalziel plot, being clearly biphasic, as it could also be seen
for  the cytosolic LiTXNPx. They reflect lower than expected rates at high
peroxide concentrations and low reductant levels. The coefficient Φ1,2, that is
formally related to the formation of a ternary complex, deviates from zero.
As elucidated from X-ray analysis of peroxiredoxins (Alphey et al., 2000; Harris
et al., 2001; Wood et al., 2002), these enzymes build decameric structures
consisting of five homodimers. The minimum functional unit is a dimer, utilizing
a unique intermolecular redox-active disulfide center for the reduction of
peroxides. Two oligomeric states are known for peroxiredoxins: The oxidized
form of the human peroxiredoxin II crystallized as a dimer (Hirotsu et al.,
1999), the preferentially aggregation state of the reduced form is being
unknown. This coincides with the oligomerization properties of AhpC from
Salmonella thyphimurium. Analytical ultracentrifugation and dynamic light
scattering showed that AhpC´s oligomeric state is redox-linked, with oxidation
favoring the dimeric state and the decameric state favored upon reduction
(Wood et al., 2002). Similar dissociation of AhpC from Mycobacterium
tuberculosis was observed by Jäger et al. (unpublished), with a higher activity
in the decameric, reduced state. No “dimer to doughnut” transition could be
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described for TbTXNPx as the ring-shaped decamer (“doughnut”) is formed in
the oxidized and reduced conformation of the enzyme. Instead of dissociation,
a clear stabilization could be detected by oxidation, as high aggregated
material could be detected by gel chromatography. In the reduced state the
main part of TbTXNPx elutes as decamers, which tend to destabilize, as pearl-
like structures appeared, that are interpreted as smaller aggregates of dimers,
(see Figure 3.17). Thus, the oligomerization of 2-Cys-peroxiredoxins seems to
be redox-sensitive, but no general mechanism is presently discernible.
The deviations from linearity in the double-reciprocal plots and the changes of
shape, dependent on the redox state of the peroxidase are incompatible with
the simple rate equation for other peroxidases. The common rate equation of
enzymatic reactions relies on the assumption of a simple interaction of
substrates with the equivalent reaction centers and could lead to wrong
mechanistic predictions for complex oligomeric enzymes such as the
peroxiredoxins (Hofmann et al., 2002; Wood et al., 2003b). From the crystal
structures of CfTXNPx (Alphey et al., 2000) and a mammalian thioredoxin
peroxidase (Harris et al., 2001) the 2-Cys-Prx were shown to build-up ring-like
structures composed of five homodimers, each having two intersubunit
reaction centers. These complex decameric structures appears to essentially
influence the activity. Formally, the shape of curves, shown in Figure 3.6,
complies with a negative cooperativity of the enzymatic reaction centers
(Koshland, 1970). The cooperativity concept was originally described by
Monod, Wyman and Changeux (Monod et al., 1965). The content of the
concept contains that the conformation of a particular subunit within an
oligomeric protein may be changed due to binding of a ligand or a reaction that
has taken place in another subunit. Such conformational changes may
positively or negatively affect the affinities or reactivities. An enzyme, which
shows cooperativity, needs four pre-requisites: (i) The protein has to be
oligomeric; (ii) binding of, or reaction with, the substrate should be associated
with conformational changes; (iii) the conformational change of the reaction
center has to enforce a conformational change in the adjacent subunit; and (iv)
the conformational change has to be functionally relevant. There are
evidences that all these criteria are met by TXNPx:
1. The minimum theoretically catalytic entitles of TXNPxs are dimers, that
built-up the active site by two inverted oriented subunits. Since the dimer of
CfTXNPx is devoid of activity and LdTXNPx and LimTXNPx lose activity
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upon dilution, probably due to dissociation, a tendency of the dimers to
form oligomers seems to have functional implications. The oligomer
structures are formed by five dimers building a ring as evident from the X-
ray structure of CfTXNPx (Alphey et al., 2000) and the electron
micrographs of LimTXNPx (Castro et al., 2002a) and TbTXNPx (Budde et
al., 2003a) and the proof of ten functional reaction centers (see Figure
3.16).
2. In reduced CfTXNPx, the sulfurs of C52 and C173´, that have to react with
each other, are up to 30 Å apart. The evidently necessary formation of a
disulfide bond during catalysis is not possible without substantial
rearrangement of the C-α backbone (see Figure 3.10) (Hofmann et al.,
2002). The tendency of oxidized decameric TbTXNPx to depolymerize
upon reduction with formation of lower MW open chain structures (see
Figure 3.12) clearly shows that the redox-dependent conformational
change is not restricted to the active site but also affects the dimer/dimer
interface.
3. Conformational changes between subunits have, to our knowledge, never
been directly demonstrated for any enzyme but, in the case of TbTXNPx, it
may be inferred from the kinetics that suggests cooperativity.
4. Molecular modeling of the reduced and oxidized state of TXNPx (Hofmann
et al., 2002) may be inferred with the functional relevance of conformational
changes: In the reduced form the only solvent-exposed sulfur is that of the
C52, while that of C173´ is shielded by an α-helix. In the oxidized form the
sulfur of C173´ becomes accessible, whereas that of C52 is buried. The
reactive thiol (C40) of the reducing substrate tryparedoxin reacts with the
C173´ to form a covalent intermediate which became evident from ESI-MS
analysis (see chapter 3.1.5.1).
To sum up, it can be said that the kinetic and morphological data suggest the
concept of negative cooperativity to adequately explain the data. The negative
cooperativity of TbTXNPx seems strange as it implies that hydroperoxide
detoxification is less efficient if the oxidant challenge is high. This particular
feature may, however, explain the well documented sensitivity of
trypanosomatids to hydroperoxide challenge (Flohé et al., 1999). The effect of
cooperativity is not only restricted to the TbTXNPx, since cooperativtiy of a
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glutathione-dependent peroxidase in Haemophilus influenze Rd (Pauwels et
al., 2003) is reported.
4.5 Clinical relevance
World-wide, 12 million people are infected by Leishmania species (WHO,
2003c), 18 million people by T. cruzi (WHO, 2003b) and the number of people
affected by African trypanosomiasis are estimated to be between 300,000 to
500,000 (WHO, 2003a). The re-emergence of sleeping sickness presents a
major public health problem, since it is one of the most important but equally
most neglected tropical infection. The diagnosis of human African
trypanosomiasis requires a high degree of training and expertise. Molecular or
serological tools have not replaced the classical parasitological procedures
until now. The treatment requires admission to hospital and is costly,
potentially dangerous, and limited by the widespread appearance of drug
resistance. The range of drugs used against sleeping sickness is limited to
Suramine, Pentamidine, Melarsoprol, and Eflornithine. Medical teams in the
field need better drugs and improved treatment schedules as they still face an
unacceptably high treatment-related mortality as well as increasing resistance
of the parasite. New drugs are therefore urgently needed (Stich et al., 2002).
The antioxidant defense of trypanosomatids differ sufficiently from those of
other eukaryotes. The pathogenic trypanosomatids do neither contain catalase
or selenium-containing glutathione peroxidases (Fairlamb and Cerami, 1992).
They are able to synthesize GSH, but transform most of it to a bis-
(glutathionyl)-derivative of spermidine, called trypanothione, using two distinct
enzymes, the glutathionyl-spermidine synthetase (GSS) and trypanothione
synthetase (TS) (Henderson et al., 1990; Koenig et al., 1997; Oza et al., 2002;
Comini et al., 2003). Unlike mammals, trypanosomatids are unable to reduce
oxidized GSH at the expense of NADPH (Ouaissi et al., 1995). Trypanothione
was shown to be present in all trypanosomatids and is maintained in the
reduced state by an NADPH-dependent disulfide reductase, trypanothione
reductase, closely related in sequence and structure to the glutathione
reductase but they both show exclusive specificity for their respective disulfide
substrates (Sullivan and Walsh, 1991; Stoll et al., 1997). Despite the use of
phylogenetically related components, the trypanosomatid system is
remarkable in being the most complex hydroperoxide detoxification system
discovered so far. In contrast to the GSH-mediated system it requires three
(trypanothione reductase, tryparedoxin, and tryparedoxin peroxidase)
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enzymes to channel the reduction equivalents from NADPH to hydroperoxide.
The thioredoxin-dependent system also requires three enzymes (thioredoxin
reductase, thioredoxin, and thioredoxin peroxidase), but does not involve a low
molecular weight mediator (Nogoceke et al., 1997). The specificity of the
hydroperoxide detoxification in trypanosomatids have made this aspect of their
metabolism an attractive target for the development of new antitrypanosomal
drugs.
The biological significance of that detoxification system has been corroborated
by inverse genetics. In L. donovani, a downregulation of TR to about 15 % of
the wild-type cells, was achieved by overexpression of a trans-dominant
mutant homologue. The parasites were able to survive in resting, but not in
cytokine-activated macrophages (Tovar et al., 1998). Bloodstream cells of T.
brucei were generated with only one functional TR gene under control of a
tetracycline-dependent promoter. Trypanosomes with less than 10 % of wild-
type activity showed arrest of proliferation, loss of virulence and increased
H2O2 sensitivity (Krieger et al., 2000). Knock-out approaches by RNAi of
TbTXNPx and TbTXN showed that both enzymes are essential for the
proliferation of the parasites. Trypanosomes, showing the knock-out
phenotype of TbTXNPx, had an increased sensitivity to H2O2 (Wilkinson et al.,
2003). TR, tryparedoxin and tryparedoxin peroxidase may thus be considered
as validated molecular targets for the development of trypanocidal drugs, but it
remains to be demonstrated if the enzymes involved in trypanothione
synthesis, may be of equal vital importance to the parasite. Therefore RNA
interference tests are planned.
The usefulness of molecular targets depends on a variety of parameters such
as (i) status of validation (ii) dissimilarity of the parasitic targets from
homologous host proteins (iii) accessibility (iv) ease and robustness of test (v)
mechanistic and (vi) structural knowledge. While the primary goal of this work
was to make available the T. brucei hydroperoxides detoxification system for
test purposes, contributions to the other aspects of target validation/
characterization were also achieved: (i) a better understanding of the system´s
kinetic peculiarities that is indispensable for the development of a reliable test
routine; (ii) confirmation of basic catalytic mechanism and (iii) details of
substrate/enzyme interactions that together with the knowledge of crystal
structures from trypanothione reductase (Krauth-Siegel et al., 1987; Hunter et
al., 1990; Kuriyan et al., 1991), tryparedoxin (Hofmann et al., 2001; Alphey et
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al., 2003) and tryparedoxin peroxidase (Alphey et al., 2000) developed, should
facilitate the design of specific inhibitors that might provide novel trypanocidal
drugs.
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5  Summary
Two genera of protozoa belonging to the order Kinetoplastida, Trypanosoma
and Leishmania, are pathogenic for mammals and cause widespread diseases
of man and his livestock in developing countries. Their successful survival
depends mainly on evading the hosts´ immune system by penetrating and
multiplying within the cells. As intracellular pathogens they need a strategy to
evade the immune response of the host, like the production of reactive oxygen
intermediates (ROI). These protozoa have evolved a hydroperoxide
detoxification system, comprising of trypanothione reductase, trypanothione,
tryparedoxin and tryparedoxin peroxidase, which differ markedly from that of
the mammalian host, since they lack catalase and selenium-containing
glutathione peroxidases. During this work the trypanothione-dependent
hydroperoxide system of T. brucei brucei was characterized and a better
understanding of  the enzyme/substrate interactions was achieved.
1. The trypanothione-dependent hydroperoxide detoxification system was
reconstituted from heterologously expressed proteins in T. brucei brucei.
TbTXNPx efficiently reduces H2O2 and organic hydroperoxides including
phosphatidylcholin hydroperoxide and is specifically reduced by TbTXN,
less efficiently by thioredoxin, but not by GSH or T(SH)2.
2. The kinetic pattern in a steady-state-kinetic analysis of TbTXNPx is
expected as it is common for other peroxidases (Nogoceke et al., 1997;
Montemartini et al., 1998a; Guerrero et al., 2000a; Flohé et al., 2002a).
The kinetic behavior of TbTXNPx deviates, as the slopes in the double-
reciprocal primary Dalziel plot are not linear and clearly biphasic. This
rather suggests cooperativity of the reaction centers, as is not uncommon
for oligomeric proteins (Koshland, 1970; Pauwels et al., 2003).
3. A kinetic characterization of LiTXNPx and LiTXN1 could be obtained that
reflect a classical ping-pong pattern. The LiTXN1 is the first active
tryparedoxin so far identified in a Leishmania species and, thus,
corroborating the trypanothione-dependent hydroperoxide detoxification
pathway in this species.
4. Different oligomeric states, depending on the redox status, are known for
peroxiredoxins (Hirotsu et al., 1999; Wood et al., 2002). A stabilization of
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the decameric form during oxidation of TbTXNPx and a tendency to
destabilize in the reduced form (pearl-like structures) could be detected by
electron microscopy.
5. The reaction mechanism of the reductive part of the TbTXNPx could be
verified. A tryptic cleavage of an intermediate, consisting of TbTXNC43S
and TbTXNPx, followed by ESI-MS/MS analysis, corroborated the
hypothetical mechanism. The solvent exposed C40 of tryparedoxin attacks
the C173´ of the peroxidase to be reduced.
6. A model of the decameric TXNPx structure showed that all ten possible
reaction centers might be active. Reductively cleavage of the dead-end
intermediate (TbTXNPx/TbTXNC43S) could confirm the predicted
stoichiometry. Ten tryparedoxin molecules bind to the decameric
tryparedoxin peroxidase.
7. LdTXNPx (Flohé et al., 2002a) consumed a broad range of hydroperoxides,
but was inactivated by lipid hydroperoxides as could be observed for
TbTXNPx (Budde et al., 2003a) and LimTXNPx (Castro et al., 2002a).
Mutagenesis studies on LdTXNPx confirmed the assumed reaction
mechanism of TXNPx with hydroperoxides, but could not efficiently explain
the substrate specificity.
8. A model for TXN/trypanothione interaction was created, based on the
known X-ray structure of CfTXN (Hofmann et al., 2001), and confirmed by
mutagenic studies. Based on that data a trypanothione homologue inhibitor
was synthesized and showed to behave as a weak comparative inhibitor.
In this study more information about the size and shape of the native TXNPx,
the reaction mechanism of the reduced TXNPx with oxidized TXN, the shape
of the catalytic intermediate TXN/TXNPx, and the interaction of TXN with
trypanothione were given. As the hydroperoxide detoxification mechanism in
trypanosomatids proved to be significant for the parasites (Tovar et al., 1998;
Krieger et al., 2000; Wilkinson et al., 2003), all components of the systems
appear as attractive targets to evolve new drugs, as urgently needed.
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7 Appendix
7.1 Abbreviations
ε extinction coefficient
∞ infinite
Φ0 reciprocal value of the velocity at infinite substrate
concentrations
Φ1 reciprocal value of the reaction velocity k´1 for the substrate
A
Φ1,2 kinetic coefficient characterizing a central complex
mechanism
Φ1app. interpolated Φ1 values
Φ2 reciprocal value of the reaction velocity k´2 for the substrate
B
[A] or [B] substrate concentration
[E0] total enzyme concentration
Å Ångström
AhpC alkyl hydroperoxide reductase subunit C
AhpF alkyl hydroperoxide reductase subunit F
APS ammoniumperoxodisulfate
ATP adenosine triphosphate
BC before Christ
bp base pair
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BSA bovine serum albumine
CD circular dichroism
Cf Crithidia fasciculata
COOH cumene hydroperoxide
C-terminal carboxy-terminal
Da Dalton
dest. destilled
DNA deoxyribonucleic acid
dNDP deoxyribonucleotide diphosphate
dNTP deoxyribonucleoside triphosphate
DSMO dimethyl sulfoxide
dsRNAi double strain RNA interference
DTT dithiothreitol
EDTA ethylene-diamine-tetraacetic acid
EFTEM energy-filtered transmission electron microscope
EGTA ethyleneglycoltetraacetic acid
EM or e. m. electron microscopy
Equ. equation
ESI electrospray ionization mass spectrometry
Ex extinction at x nm wavelength
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FPLC high performance liquid chromatography for fast protein
purification
g gravitation
GBF German Research Centre for  Biotechnology
GFP green flourescence protein
GPx glutathione peroxidase
GR glutathione reductase
Grx glutaredoxin
GSH glutathione
Gsp glutathionyl-spermidine
GspS glutathionyl spermidine synthetase
HBP heme-binding protein
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
i. e. it est
IgG immune globuline G
IMAC immobilized-metal affinity chromatography
IPTG isopropyl-β-D-thiogalactopyranoside
k´1 reaction velocity of an enzyme reacting with substrate A
120                                                                                                                                APPENDIX
k´2 reaction velocity of an enzyme reacting with substrate B
kcat. reaction velocity at infinite substrate concentrations
KM x Michaelis Menten constant for the substrate x
LB Luria Bertani
Lc Leishmania chagasi
Ld Leishmania donovani
Li Leishmania infantum
Lm Leishmania major
LOOH 13-hydroperoxy octodecadienoic acid hydroperoxide
MALDI-TOF matrix-assisted laser desorption and ionization time-of-flight
MEM  minimum essential medium
MS mass spectrometry
MS/MS tandem mass spectrometry
MST 3-mercaptopyruvate sulfurtransferase
MW molecular weight
NADPH nicotinamide adenine dinucleotide phosphate
NDP nucleotide diphosphate
Ni-NTA nickle-nitrilotriacetic acid
N-terminal amino-terminal
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ODx optical density at x nm wavelength
PAGE polyacrylamide gel electrophoresis
PC procyclic
PCOOH soybean lipoxygenase-peroxidized phosphatidyl cholin
hydroperoxide
PCR polymerase chain reaction
PEG polyethylenglycol
Prx peroxiredoxin
PVDF polyvinylidendifluoride
RiboR ribonucleotide reductase
RNA ribonucleic acid
RNI reactive nitrogen intermediates
ROI reactive oxygen intermediates
rpm rounds per minute
RT room temperature
SDS sodium dodecyl sulfate
spec. act. specific activity
T(SH)2 trypanothione
Taq Thermophilus aquaticus
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Tb Trypanosoma brucei brucei
TBE tris-borate EDTA
t-bOOH tertiary-butyl hydroperoxide
TBS Tris buffered saline
Tc Trypanosoma cruzi
TE Tris-EDTA
TEMED N,N,N´,N´-tetramethylethylethylenediamine
TR or TryR trypanothione reductase
Trx thioredoxin
TrxPx thioredoxin peroxidase
TrxR thioredoxin reductase
TryS trypanothione synthetase
TSS Transformation and storage solution
TXN tryparedoxin
TXNPx tryparedoxin peroxidase
UV ultraviolet
v initial velocity
v/v volume per volume
vapp. interpolated apparent velocities
Vmax. app. apparent maximum velocities
Vmax. interpolated maximum velocity of an enzyme
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VSG variant surface glycoprotein
w/v weight per volume
WHO World Health Organization
7.2 Abbreviations of nucleotides and amino acids
Base Abbreviation
Adenosine A
Cytidine C
Guanosine G
Thymidine T
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Amino acid Three letter code One letter code
Alanine Ala A
Arginine Arg R
Asparagine Asn N
Aspartatic acid Asp D
Cysteine Cys C
Glutamic acid Glu E
Glycine Gly G
Histidine His H
Isoleucine Ile I
Leucin Leu L
Lysine Lys K
Methionine Met M
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Threonine Thr T
Tryptophan Trp W
Tyrosine Tyr Y
Valine Val V
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7.3 List of Primers
Name of the primer Sequence of the primer
TbTXN Forward 5´ GCC GCG CAT ATG TCT GGC
CTC GCC AAG TAT CTT 3´
TbTXN Reverse 5´ GCC GCG CTC GAG GTT GGG
CCA CGG AAA GTT GGC 3´
TbH6TXN Reverse 5´ CGG CGC CTC GAG TCA GTT
GGG CCA CGG AAA GTT 3´
TbTXNPx Forward 5´ GCC GCG CAT ATG TCC TGC
GGT GAT GCG AAA CTC 3´
TbTXNPx Reverse 5´ GCC GCG CTC GAG TTA GTT
CAT GCT GCT GAA GTA 3´
TbTXNC43S Forward 5´ TCC TGG TGC CCC CCA TCC
CGG GT 3´
TbTXNC43S Reverse 5´ ACC CCG GGA TGG GGG GCA
CCA GGA 3´
TbTXNC40A Forward 5´ GCC TCC TGG TCC CCC CCA
TGC CGG 3´
TbTXNC40A Reverse 5´ CCG GCA TGG GGG GGA CCA
GGA GGC 3´
TbTXNE72R Forward 5´ CC TGG GAT CGC AAC GAG AGC
G 3´
TbTXNE72R Reverse 5´ C GCT CTC GTT GCG ATC CCA
GG 3´
TbTXND76K Forward 5´ C GAG AGC AAA TTC CAT GAT
TA 3´
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Name of the primer Sequence of the primer
TbTXND76K Reverse 5´ GTA ATC ATG GAA TTT GCT CTC
G 3´
TbTXND79K Forward 5´ C GAC TTC CAT AAA TAC TAC
GGC 3´
TbTXND79K Reverse 5´ GCC GTA GTA TTT ATG GAA
GTC G 3´
TbTXND76/79K Forward 5´ GAG AGC AAA TTC CAT AAA TAC
TAC G 3´
TbTXND76/97K Reverse 5´ C GTA GTA TTT ATG GAA TTT
GCT CTC 3´
TbTXNR128D Forward 5´ C ACT CAG GCC GAT ACC CGT
GTC 3´
TbTXNR128D Reverse 5´ GAC ACG GTT ATC GGC CTG
AGT 3´
TbTXNPxC52S Forward 5´ C ACG TTT GTG TCC CCC CAC
TGA 3´
TbTXNPxC52S Reverse 5´ TC AGT GGG GGA CAC AAA CGT
G 3´
TbTXNPxC173S Forward 5´ GGT GAG GTG TCC CCC GCT
AAC 3´
TbTXNPxC173S Reverse 5´ GTT AGC GGG GGA CAC CTC
ACC 3´
CfTXN2E73R Forward 5´ G GAT CGG TCA GCA GAG GAC
TTT AAG G  3´
CfTXN2E73R Reverse 5´ C CTC TGC TGA CCG ATC CCA
GGA GAT GAG CAT CAC C 3´
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Name of the primer Sequence of the primer
CfTXN2R129D Forward 5´ GGC GGA CAC GAT GGT GGT
GAA GG 3´
CfTXN2R129D Reverse 5´ CC ACC ATC GTG TCC GCC TGC
GTT GTG ATG ATG TT 3´
LdTXNPxC173S Forward 5´ G AAG CAC GGC GAG GTG TCC
CCC GCG AAC TCG GAG 3´
LdTXNPxC173S Forward 5´CTT CCA GTT CGC GGG GGA
CAC CTC GCC GTG CTT C 3´
Table 7.1: List of primers used in this thesis. Restriction sites are shown in bold and
italics; Stop codons are marked in bold; Mutated amino acids are highlighted in italic.
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